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ABSTRACT

CIGARETTE SMOKE, DNA DAMAGE AND REPAIR IN HUMAN
CERVICAL AND VAGINAL CELLS IN VITRO AND EX VIVO

Afsoon Moktar
September 17, 2010

Among gynecological malignancies, carcinoma of the cervix is the
leading cancer type worldwide. Conversely, vaginal tumors account for an
incidence of approximately 1-2% of lower genital tract malignancies.
Interestingly, the major shared risk factor among women with cervical and
vaginal

tumors

is

infection

with

cancer-associated

human

papillomaviruses (HPVs). In fact, HPV infection is the necessary causative
factor in the development and progression of cervical and vaginal
neoplasia in the majority of cases. Epidemiological studies support that
cervical and vaginal pre-cancerous lesions that are initiated by HPV
infection generally regress in the absence of known risk factors such as
cigarette smoking. Further, female smokers have two times higher risk of
developing cervical cancer from premalignant lesions than non-smokers,
although the association between cigarette smoking and vaginal tumors
has been controversial. Cigarette smoking exerts its cytogenetic effects in
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various forms such as DNA strand breaks and oxidative DNA damage.
However, previous studies on cervical and vaginal abnormalities failed to
investigate the effects of cigarette smoking on cervical and vaginal cells
from a biological standpoint.
Therefore, the goal of this work was to investigate cigarette smokeinduced DNA strand breaks, oxidative damage and DNA repair in human
cervical cancer cells (in vitro studies, Chapters II and III); we also
examined DNA strand breaks in human vaginal cells in light of cigarette
smoking and HPV status (an ex vivo study, Chapter IV). It was determined
that cigarette smoke induces both DNA single- (SSBs) and double-strand
breaks (DSBs) that are highly persistent, in addition to oxidative DNA
damage, which is more pronounced in HPV infected human cervical
cancer cells.

Though,

CSC-induced

oxidative

DNA damage was

eventually removed in the cells, the possibility of error-prone DNA repair,
however, cannot be ruled out. Lastly, our data derived from the ex-vivo
study clearly showed an inverse relationship between the interaction of
cigarette smoking and HPV infection in the induction of DNA strand breaks
in vaginal cells of the studied population, regardless of age. Further, we
have clearly showed that the extent of DNA DSBs increases as a function
of age, which corroborates with the fact that vaginal cancers occur at a
much older age, as compared to cervical cancers. In summary, the
findings of this research project shed light on the role of cigarette smoke in
cervical/vaginal carcinogenesis. Moreover, comet assay might serve as an

Vll

early biomarker in identifying susceptible populations that are at risk for
developing cervical/vaginal abnormalities.
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CHAPTER I

INTRODUCTION

1

The main focus of this dissertation was to investigate the effect of
cigarette smoke on DNA damage and repair in human cervical cancer and
vaginal cells since cigarette smoking is considered a significant cofactor in
association with high-risk HPV infection in cervical/vaginal carcinogenesis.
Two types of DNA lesions, namely, DNA strand breaks and oxidative DNA
damage were analyzed. The findings of this study would serve as an
essential step in identifying susceptible populations that are at risk for
developing cervical/vaginal abnormalities.

1.

CervicalNaginal Cancer Statistics

Cervical cancer is one of the leading cancer types among women
worldwide, although it has the greatest potential for prevention (World
Health Organization, PAHO, 2004). In the United States, an estimated
11 ,270

cases

of

invasive

cervical

cancer

were

diagnosed

and

approximately 4,070 deaths from cervical cancer occurred in 2009 [1]. In
Kentucky, investigations on cervical cancer is of particular importance,
since the age-adjusted incidence rate of this cancer for 2002-2006 is
higher than the average rate in the United States (9.48 versus 8.26 per
100,000) (Kentucky Cancer Registry 2007). In 2004, current smoking
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prevalence in Kentucky was the highest in the nation at a rate of 27.6%
(Center for Disease Control, 2005).

The high prevalence of cervical

cancer has been associated with increased cigarette smoking in the state
[2]. Based on the Kentucky Cancer Registry data, 61 % of women
diagnosed with cervical cancer during 1997-1998 had a history of tobacco
use [2].
Vaginal intraepithelial neoplasia is a rare disorder with an incidence
of approximately 0.2 to 0.3 per 100,000 women [3]. Primary vaginal
cancer is extremely rare and accounts for about 1- 2% of all gynecological
malignancies

[4].

However,

the

incidence

of

secondary

vaginal

malignancies is 80-90% due to the anatomic proximity of the vagina to the
urinary bladder and rectum. The primary tumors in those locations can
spread to the vagina either by direct extension or by lymphatic metastasis
[3]. According to Kentucky Cancer Registry, in 2007, approximately 59%
of women who were diagnosed with vaginal cancer were smokers
(Kentucky Cancer Registry 2007). Therefore, studying the role of cigarette
smoking in cervical and vaginal carcinogenesis could provide prophylactic
and therapeutic applications that may ultimately be beneficial to women at
high risk of or diagnosed with HPV-induced cervical/vaginal abnormalities.

3

2.

CervicalNaginal Cancer Histopathology

The morphology of cervical cancer and its pre-cancerous lesions
are well defined [5], providing an excellent opportunity to study the
etiology and to strategize prevention of this multi-staged cancer. Based on
the National Cancer Institute Bethesda System 2001, cervical squamous
epithelial abnormalities are classified as follows:

1.

Atypical

squamous

cells

(ASC),

which

encompass

two

subcategories: a) Atypical Squamous Cells of Undetermined Significance
(ASC-US); and b) ASC with the possibility of high-grade squamous
intraepithelial lesions (ASC-H)
2.

Low-grade squamous intraepithelial lesions (LSIL), including mild

cervical intraepithelial neoplasia (CIN I) and HPV
3.

High-grade squamous intraepithelial lesions (HSIL), including

moderate to severe intraepithelial neoplasia (CIN II/CIN III) and carcinoma
in situ (CIS)
4.

Invasive squamous cancer

The progression of cervical intraepithelial neoplasia from CIN I to
CIN II, CIN III and invasive cancer is based on cytological and epithelial
architecture abnormality [5]. Less than 5% of low-grade (CIN 1/11) cases
will progress to high-grade lesions (CIN III), whereas only a small

4

percentage of these will be associated with squamous cervical cancer [6].
On the contrary, approximately 36-76% of high-grade lesions will progress
to cervical cancer in about 20 years [6]. The factors influencing the
progression or regression of the neoplastic lesions are two-fold: genetic
and environmental determinants [7].
The classification of vaginal intraepithelial neoplastic lesions is
similar to CIN and is classified according to the depth of epithelial
involvement [8]:
1.

VAIN I: the involvement of the lower one-third or less of the

distance from the basement membrane to the surface.
2.

VAIN II: less than or equal to two-thirds involvement.

3.

VAIN III: more than two-thirds of the distance is involved.

Carcinoma in situ (CIS), which the entire thickness of the epithelium is
involved, is also classified under VAIN III.
4.

Invasive vaginal cancer: vaginal mucosa, submucosa or connective

tissue is involved without cervical or vulvar invasion.
Vaginal cancer is usually clustered with "other and unspecified
gynecologic neoplasms" including vulvar and fallopian tube cancers due to
its rarity [8]. Vaginal cancers are considered primary if there is no clinical
or histological involvement of the cervix or vulva [9-10].
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3.

Cervical versus Vaginal Epithelia

The cervical epithelium is composed of columnar and stratified nonkeratinizing squamous types. The squamocolumnar junction (also known
as T -zone) is where those epithelia meet. T -zone is the most important
cytologic landmark, since most cervical dysplasias arise from this area.
Squamous metaplasia is a dynamic process that occurs throughout the
reproductive age in the T-zone, and is a normal physiological process
during which columnar epithelium is replaced by squamous type. Acidic
vaginal pH and estrogen account for replacement of more delicate
columnar epithelium with a more robust squamous type. There are two
mechanisms responsible for this normal process:

1) reserve cell

hyperplasia, a proliferation of reserve cells around the columnar glands,
which eventually leads to the replacement of the epithelium; and 2) growth
of squamous epithelium toward the center of ectocervical epithelium
resulting in metaplasia, which, in turn, replaces the overlying columnar
epithelium. The significance of the T -zone arises from the fact that almost
all cervical neoplastic lesions originate from this area. During pregnancy
and peripubertal years, the T-zone is predominantly active, which
accounts for the observation that early first sexual intercourse and early
age at first

pregnancy are among cervical

cancer risk factors.

Furthermore, it is thought that reserve cells in adolescent and young
women are more vulnerable to the carcinogenic HPV infection [11-12].
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The epithelium of vagina is stratified non-keratinizing squamous
type. The epithelial cells of vagina are classified into three types:
parabasal,

intermediate

and

superficial

cells,

which

reflect

a

developmental continuum [11].
The vagina lacks a squamocolumnar junction [13], which is not
necessary for HPV infection, although high-risk HPV distinctively affects
the T-zone [14].

4.

CervicalNaginal Cancer Etiology and Risk Factors

Cervical cancer risk factors can be divided into three groups: 1)
viral cofactors, such as HPV variants, viral load and viral integration; 2)
host cofactors, such as endogenous hormones and genetic influences;
and 3) environmental cofactors, such as diet, use of oral contraceptives,
parity, cigarette smoking [15-16] and low socioeconomic status [17]
(Figure 1.1). It has been shown that parity and cigarette smoke are more
consistently associated with the progression of cervical neoplasia toward
cervical cancer [15]. The epidemiological and clinical data indicate that
HPV infection is necessary but not sufficient for development and
maintenance of cervical carcinoma [18-20], since the majority of HPV
infections regress [21]. A typical epidemiological profile of CIN includes
multiple sexual partners, earlier ages at first sexual intercourse, cigarette
smoking, and lower-socioeconomic status with a strong association with
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HPV infection [22]. In fact, the HPV prevalence in cervical carcinoma is
99.7% worldwide, which accounts for the greatest causative factor
involved in development of any human cancer [23].
Human papillomaviruses belong to the Papovaviridae family with a
double-stranded DNA [24]. Three regions are identified in HPV genome:
the long control region (LeR), which has no coding potential; the early
proteins region (E1-E8); and the region of late proteins (L 1 and L2), which
are structural proteins [24]. There are at least 200 types of HPV viruses
that are classified into 16 groups according to their ability to induce
malignant transformation [24]. HPV types 16, 18, 31, 33, 35, 39, 45, 51,
52, 56, 58, 59, 68, 73, and 82 are classified as carcinogenic or high-risk
types [25]. Among these carcinogenic types, HPV 16 and 18 are the most
closely associated with cervical cancer, with a high prevalence of HPV 16
[26].
In benign cervical precursor lesions, the HPV DNA is usually
extrachromosomal or episomal, whereas in many cervical cancer cells as
well as in cervical cancer cell lines and HPV-transformed human
keratinocytes, the HPV DNA is integrated in the host genome [27]. Upon
integration of HPV DNA, the viral genome usually breaks in the E1/E2
region and is usually lost [27]. Moreover, disruption of E2-encoding gene
causes the loss of expression of viral E2 protein causing uncontrolled
overexpression of E6 and E7 oncogenes, which is the hallmark of HPVinduced cervical carcinoma [27-28]. The most significant oncogenes are
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E6 and E7, which playa major role in HPV-associated tumorigenesis [29].
In malignant tissue, E6 and E7 genes are consistently expressed.
Furthermore, if their expression is inhibited, the malignant phenotype of
cervical cancer cells is blocked [30]. E6 and E7 oncoproteins cause
genomic

aberrations,

mitotic defects,

and

numerical

chromosome

instability, ultimately leading to carcinogenic progression [31]. The E6
oncoprotein degrades the cellular protein p53 via the ubiquitin-proteasome
pathway [32]. E6, then suppresses the p53 gene products [27]. The E7
oncoprotein interacts with the retinoblastoma protein (pRb) and inactivates
[33]. pRb plays a crucial role in cell cycle control [34]. Even though HPV is
a necessary factor in developing cervical abnormalities, it does not suffice
as a cervical carcinogen, since the majority of the HPV infections are
short-lived [35]. Additional cofactors are required to prolong expression of
the HPV E6 and E7 oncogenes and genetic instability [36].
The majority of vaginal cancers have common risk factors with
cervical cancer; the most reported shared risk factor among women with
cervical and vaginal tumors is infection with cancer-associated HPV types.
High-risk HPV prevalence is comparable in cervical and vaginal samples,
which, in turn, signifies that both tissues can retain cancer-associated
HPV infection [14].
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5.

Cigarette Smoke Constituents

The chemical constituents of cigarette smoke have been the
subject of extensive chemistry analysis. It is well known that smoke
toxicants are important in the development of various diseases, including
cancer. More than 5,000 smoke constituents have been identified in
cigarette smoke and approximately 60 to 70 of those are known toxic
constituents of tobacco smoke [37]. Tobacco smoking was first listed as a
human carcinogen in the 9th Report on Carcinogens 2000. This
identification was based on human studies indicating a casual relation
between tobacco smoking and cancer (US Department of Health and
Human Services, Report on Carcinogens, 2000). Tobacco smoking has
been demonstrated to cause variety of human cancers such as lung, oral
cavity, lips, larynx, esophagus, and urinary bladder [38]. According to the
U.S. Department of Health and Human Services, the cigarette smoke
carcinogens can be summarized in Table 1.1 (US Department of Health
and Human Services, Report on Carcinogens, 2006).
Cigarette smoke contains a complex mixture of products resulting
from organic substance combustion (acetaldehyde and formaldehyde) and
from chemicals generated by the combustion of tobacco and the
cigarette's other components (tobacco-specific nitrosamines) (US Surgeon
General Reports, 1988). The International Agency for Research on
Cancer (IARC)

has listed 36 chemicals that are known human

carcinogens. Ten of these compounds, in addition to many more
10

mutagenic chemicals fall into Group 2 of IARC's classification of "probably
or possibly carcinogenic" categories (IARC, 1999). Furthermore, the U.S.
Environmental Protection Agency and IARC put cigarette smoke in Group
1 classification as a known carcinogen in humans.
The U.S. Surgeon General has defined "tar" as the nicotine-free,
dry, and particulate mass of the tobacco smoke that contains many
harmful carcinogenic compounds, such as metals, polycyclic aromatic
hydrocarbons (PAHs), dioxins and nitrosamines (US Surgeon General
Reports, 1988). PAHs are generated through combustion of any organic
compound; the highest toxicologically potent of those compounds is
benzo[a]pyrene (BP), which is extensively studied in relation to human
carcinogenicity [37].
The University of Kentucky's Tobacco and Health Research
Program developed a cigarette, the 2R4F, which was used as an universal
standard for research purposes and provided a basis for data comparison
among scientific communities [39]. Other reference cigarettes, such as
1R3F and 1R5F that have been used in research, differ in the amount of
chemical constituents compared with 1R4F (Table 1.2) [40].

6.

Role of Smoking as a Cofactor in CervicalNaginal Cancer

Cigarette smoke as a causative factor in the development of
cervical cancer was proposed by Winkelstein [41]. Based on numerous
epidemiological studies, cigarette smoke is a significant risk factor in
11

developing cancer of numerous organs [42], including the uterine cervix
(Figure 1.1) [26, 43-44]. Considering the fact that the cause of cervical
cancer is multi-factorial and HPV infection alone is not sufficient, although
necessary, the association of HPV and cigarette smoke has been
suggested [44-46]. The following data support the hypothesis that
cigarette smoking is a cofactor with HPV infection in cervical cancer
etiology [47]:
1.

There is strong association between smoking and CIN II/III/invasive

cervical cancer [48]. It has been proposed that cigarette smoke has a late
stage synergistic effect in cervical carcinogenesis already initiated by HPV
infection [15, 49]. Infection with HPV 16 is demonstrated to be associated
with high-grade lesions (HSIL), with increasing risk of HSIL directly related
to number of cigarettes smoked per day [50]. Nakao and Yang et al. used
an in vitro model system to demonstrate that cigarette smoke may be
required as a co-carcinogen in the neoplastic progression of HPV-initiated
high-grade cervical lesions [51-52].
2.
as

Detection of tobacco specific carcinogens in cervical mucus such
nicotine

and

cotinine

and

4-(methylnitrosamino)-1-(3-pyridyl)-1-

butanone (NNK) ([53-55] has been reported. These findings support the
epidemiological data indicating that cigarette smoking is an actual risk
factor in cervical carcinogenesis.
3.

The association of cigarette smoking as a casual cofactor in

development of cervical abnormalities is further strengthened by the

12

evidence that tobacco-specific compounds, such as nitrosamine 4(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene [56-57]
can be metabolized by human cervical epithelium into carcinogenic and
genotoxic products.
4.

It has been documented that tobacco smoke is an extreme

example of systemic human mutagen [58]. The effect of cigarette smoke
condensate and cigarette smoking, in inducing DNA damage, mainly DNA
strand breaks, has been demonstrated by many studies [59-62]. Chemical
carcinogens in cigarette smoke, such as nitrosamines, may damage DNA
as well as impair local immune response of cervical epithelium [63].
Cigarette smoke exerts its cytogenetic effects in various forms, including
micronuclei,

sister

chromatid

exchange,

chromosomal

aberrations,

microsatellite instability, DNA strand breaks and oxidative damage [58].
5.

Female smokers with HPV-associated low grade cervical lesions

have up to three times higher risk of developing cervical cancer than
nonsmokers [48]. Further, cigarette smoking cessation decreases the size
of early cervical lesions [64]. Therefore, behavioral modification to
decrease the rate of cigarette smoke consumption [65] may have a
positive effect on cervical cancer progression and/or development.
Epidemiological and etiological variables, such as cigarette smoking,
associated with cervical cancer have also been reported to be pertinent to
the etiology of vaginal tumors [66]. Few studies have reported a positive
association between cigarette smoking and vaginal abnormalities [67-70].
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These studies were based on an epidemiological association. However,
conflicting data exist on the role of smoking in the development and
progression of HPV lesions in vaginal cells. Hellman et al demonstrated
that vaginal carcinoma was not significantly correlated with smoking [71].
Madsen et al found that current smoking was a risk factor in HPV infected
individuals [66]. Another study by Brinton et al showed a modest nonsignificant correlation between smoking and vaginal cancer [72]. Thus, the
role of cigarette smoking as a cofactor in vaginal cancer remains
controversial. Nonetheless, the exact mechanism by which cigarette
smoking exerts its cytotoxic effects is not entirely understood.

7.

Oxidative stress, cigarette smoke and cervical cancer

Reactive oxygen species (ROS) are abundant free radicals in
nature and playa significant role in induction of DNA damage [73]. Normal
cellular processes, such as respiration, inflammation, cell injury and
hydroxylation of steroids and drugs are endogenous sources of ROS [74].
ROS can induce damage in DNA, protein and lipid [75]. Oxidative stress is
caused by the imbalance between the ROS production, scavenging and
removal/repair of the resulting damage. Therefore, oxidative stress is
considered a critical mechanism in the pathogenesis of many diseases
including cancer [76-77]. Oxidative stress oxidizes cellular components,
activates signal

transduction

pathways,

14

affects gene

and

protein

expression and alters activity of DNA polymerase leading to its low fedility
conformation [78]. The exceptionally important target of oxidation is DNA,
since mutations induced by such damage may be passed on to many
generations.

The

oxidation

of

guanine

to

8-oxo-7,8-dihydro-2'-

deoxyguanosine (8-oxodG) is the most commonly studied oxidative lesion
[79] (Figure 1.2). This lesion may lead to G.C-' T.A transversions [80].
Formation of an oxidative lesion may lead to accumulation and
persistence of mutation, which may, in turn, playa role in carcinogenicity
[81-82]. Furthermore, the environmental sources of ROS, such as
cigarette smoke, are of particular importance in cancer pathogenesis [75].
Cigarette smoke can induce different oxidative DNA lesions, including 8oxodG [83]. In fact, the role of 8-oxodG formation in cigarette smokeinduced carcinogenesis has been suggested by many studies. The levels
of this base lesion were reported higher in smokers as compared to nonsmokers [84-86].

8.

Cigarette Smoke, DNA repair and Cervical Cancer

DNA repair machinery is one of the primary defense mechanisms in
our body against mutagenic agents. There are two subgroups of DNArepair genes: 1) genes associated with regulation of DNA repair, and 2)
genes associated with defined repair mechanisms, such as mismatch
repair (MMR), nucleotide-excision repair (NER), base-excision repair
(BER), and double-strand-break (DSB) repair [87]. The NER pathway is
15

responsible for removing bulky DNA adducts caused by tobacco smoke,
the SER pathway removes oxidized DNA bases caused by endogenous
agents and/or oxidants in cigarette smoke, and DSS repairs double-strand
breaks [88]. Homologous recombination (HR) and non-homologous end
joining are the two complementary pathways of DSS repair [88]. DNA
lesions, or persisting DNA strand breaks [89] and impaired DNA repair
system may contribute to genomic instability.
Tobacco

smoke

carcinogens

damage

DNA

[62],

which

subsequently involve repair pathways, particularly, NER, SER, and DSS
repair pathways; the genes of those pathways may be involved in the
initiation of tobacco-caused cancer [90]. In general, upon exposure to precarcinogenic compounds, the balance between an intact DNA repair
system and genetic susceptibility may influence conversion of precarcinogenic compounds to DNA damaging agents [91] (Figure 1.3).

9.

p53 and Cervical Cancer

The continued simultaneous expression of high-risk HPV E6 and
E7 proteins in cervical cancer causes the inactivation of p53 and pRS
tumor suppressor pathways, respectively [92]. The tumor suppressor p53
primarily functions as a transcription factor, but several responses can be
generated by p53, including cell cycle arrest or apoptosis [93]. p53 gene
mutations are the most frequently occurred genetic abnormalities in
human cancers [94]. The role of p53 in cervical pathogenesis is two-fold.
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First, the short arm of chromosome 17, which is the location of p53,
showed frequent abnormalities by karyotype analysis of cervical cancer
specimens [95]. Second, the E6 oncoprotein of high-risk HPV binds to and
promotes degradation of p53 [96] through a ubiquitin-dependent protease
system [97]. p53 is inactivated in cervical carcinoma, either by its mutation
or binding to E6 oncoprotein [98]. p53 mutations frequently occur in HPVnegative cervical carcinoma cell lines as compared to HPV-positive lines
[99-100].
The role of p53 as an important sensor of cellular stress depends
on the cell type and extent of stimuli; p53 can induce cell cycle arrest to
permit repair [101]. Alternatively, p53 can induce apoptosis to prevent
fixation of DNA mutation in stressed cells [101]. There is also evidence,
however, that p53 has a more positive role in facilitating the repair of
oxidative damage. First, activation of several p53-regulated genes yields
products that act as antioxidants, such as GPX1 and ALDH4A 1 [102-103].
Second, two p53-regulated sestrins, namely PA26 and Hi95, can
reactivate peroxiredoxins, a ubiquitous family of antioxidant enzymes[1 04].
Third, several antioxidant genes are up-regulated by p53 resulting in a
decrease of RDS levels[105].
Most HPV-positive cervical carcinoma cells include the wild-type
p53 gene, although it is usually non-functional as a result of binding to E6
oncoprotein, which facilitates its degradation via an ubiquitin-dependent
proteolytic pathway [106]. However, HPV-positive cervical cancer cells

17

have been shown to have residual p53 activity, indicating that p53 is not
completely inactivated by binding to the E6 oncoprotein [107-109]. The
p53 gene is often mutated in HPV-negative cervical cancer cell lines [110].

10.

Rationale/Importance of the Current Studies

Worldwide, cervical cancer is the second leading cause of cancer
death after breast cancer among women and the leading cause of cancer
death in women in developing countries [111]. The World Health
Organization estimates that 4.5 million smoke-related deaths, which are
the most preventable cause of deaths, occur each year [111]. Cervical
cancer in the United States and on a global scale is, therefore, an
important public health problem. The issue of smoking is of particular
interest in Kentucky, where the prevalence of tobacco smoking is very
high (Kentucky Cancer Registry 2007). Moreover, based on available data
on cervical cancer cases obtained from the Kentucky Cancer Registry
from 1995-2005, Coker et al showed that cigarette smoking reduces
cervical cancer survival [112]. The majority of women diagnosed with
cervical cancer during 1997-1998 had a history of tobacco use [2, 112].
These statistics highlight the importance of investigating the plausible link
between cigarette smoke and cervical cancer to identify the high-risk
population and lessen the economic and disease burden of Kentucky as
well as nationwide. Since cigarette smoking is a strong epidemiological
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and etiological risk factor for cervical and vaginal cancer progression,
investigation on the effect of cigarette smoke on DNA damage and repair
in association with HPV infection in those cancers is warranted.
This study examines the role of cigarette smoke on DNA damage
and repair. The findings of this study would serve as an essential step in
identifying susceptible populations that are at risk for developing
cervical/vaginal abnormalities by developing early biomarkers. Future
investigations will be warranted to employ the early biomarkers developed
in this study for clinical settings in order to prevent cervical precancerous
and cancerous lesions in high-risk population. Furthermore, susceptible
individuals can be subject to behavioral modification sessions to refrain
from smoking and be enrolled in chemoprevention studies. In conclusion,
the data from this study would serve as a stepping stone towards the
ongoing efforts on primary prevention of cervical/vaginal cancer.
Chapter II focuses on cigarette smoke condensate (CSC)-induced
DNA strand breaks and their removal in a human HPV-transfected cervical
cell line. The role of ellagic acid, a potent antioxidant, in the removal of
DNA damage was also examined in this chapter. CSC-induced oxidative
DNA damage and its removal in human cervical cancer cell lines, in
association with HPV, are examined in Chapter III. Chapter IV, an ex vivo
study, investigates the effect of cigarette smoking alone and in association
with high-risk HPV infection in human vaginal cells.
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11.

Rationale for Selecting Vaginal Cells for Ex vivo Study:

Pap smear contains a heterogeneous cell population, including
variety of epithelial and non-epithelial cells. To assess the DNA strand
breaks at a cellular level, in ex vivo study, the first objective was to obtain
a homogenous sample containing only epithelial cells. Several attempts
were made to isolate epithelial cells, including magnetic and Percoll
separation. However, even though the level of cell purity was acceptable,
the cell recovery did not achieve any significant numbers. Therefore,
collecting vaginal cells seemed to be the only plausible option to
specifically assess DNA damage on the selected cell type.
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Figure 1.1: HPV and non-HPV factors that contribute to HPV-

induced

malignant

progression

[30].

LSIL:

Low-grade

squamous intraepithelial lesion; HSIL: High-grade squamous
intraepithelial lesion.
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TABLE 1.1
List of Cigarette Smoke Carcinogens

Amount (per cigarette)

Chemical
Acetaldehyde
Acrylonitrile

4-Aminobiphenyl
o-Anisidine Hydrochloride
Arsenic
Benzene
Beryllium
1,3-Butadiene
Cadmium
1,1-Dimethylhydrazine
Ethylene oxide
Formaldehyde
Furan
Heterocyclic amines
Hydrazine
Isoprene
Lead
2-Naphthylamine
Nitromethane
N-Nitrosodi-n-Butylamine
N-Nitrosodiethanolamine
N-Nitrosodiethylamine
N-Nitrosodimethylamine
N-Nitrosodi-n-Propylamine
4-(N -Nitrosomethylamino)-1-(3Pyridyl)-I-Butanone
N-Nitrosonornicotine
N-Nitrosopiperidine
N-Nitrosopyrrolidine
N-Nitrososarcosine
Polonium-210Citation needed
Polycyclic aromatic
hydrocarbons
0- Toluidine
Vinyl chloride

980 micro~rams to 1.37 milli~rams
Formerly 1 to 2 milligrams. This product was
used as a fumigant in tobacco. Its use has since
been discontinued.
0.2 to 23 nano~rams per ci~arette
unknown
unknown
5.9 to 75 micro~rams
0.5 nanograms
152 to 400 micro~rams
1.7 micro~rams
unknown
unknown
unknown
unknown
unknown
32 micrograms
:3.1 milligrams
unknown
1.5 to 35 nano~rams
unknown
3 nano~rams
24 to 36 nano~rams
up to 8.3 nano~rams
5.7 to 43 nano~rams
1 nanogram
up to 4.2 micrograms
14 micro~rams
unknown
113 nanograms
22 to 460 nanograms
variable, depending on soil and fertilizer used to
~row tobaccoill
80 to 160 micrograms
32 nanograms
5.6 to 27 nanograms

From: 11th Report on Carcinogens by the U.S. Department of Health
and Human Services, 2009.
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TABLE 1.2
Reference C·Igarettes A nalyses
1R3F'
1R5F2
2R4F<!

TPM
mg/CIG

FTC TAR
mglCIG

NICOTINE
mg/CIG

18.10
2.08
11.7

15.0
1.67
9.7

1.16
0.16
0.85

30 mm butt length (Length of cigarette butt remaining after smoking)
2 3Smm butt length (Length of cigarette butt remaining after smoking)
1

TPM - Total Particulate Matter
FTC - Federal Trade Commission
CIG - Cigarette
From: Chambers, O. The Reference Cigarette. College of Agriculture,
Reference Cigarette Program.
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CHAPTER II

CIGARETTE SMOKE-INDUCED DNA DAMAGE AND REPAIR
DETECTED BY THE COMET ASSAY IN HPV-TRANSFORMED
CERVICAL CELLS
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A.

Introduction
Epidemiological and clinical data strongly support a major role by

the Human Papillomavirus (HPV) in the etiology of cervical cancer [18-19,
23]. However, HPV alone appears to be insufficient for cervical cancer
development as studies have shown that the majority of HPV infection is
cleared by the immune response within 8-12 months [21]. Further,
additional cofactors were found to be required for prolonged expression of
the HPV E6 and E7 oncogenes leading to development and progression
of cervical abnormalities [36]. One major risk factor in HPV-mediated
cervical cancer is cigarette smoking, as it has been consistently linked
with the progression of cervical neoplasias to invasive carcinoma [15].
Further, female smokers have two times higher risk of developing cervical
cancer than non-smokers [114].
Cigarette smoke-induced genotoxicity results in induction of
micronuclei,

sister chromatid

exchange,

chromosomal

aberrations,

microsatellite instability, DNA strand breaks and oxidative DNA damage
[58, 115]. Cigarette smoke is a heterogeneous mixture of approximately
5,000 chemical compounds, of which several dozens of them are
carcinogens, co-carcinogens, mutagens and tumor promoters [116],
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including

polycyclic

aromatic

hydrocarbons

(PAH),

N-nitrosamines,

inorganic and organic compounds [117-118].
Cigarette smoke has been shown to cause a variety of oxidative
DNA

damage,

including

the

formation

of

8-oxo-7,8-dihydro-2-

deoxyguanosine (8-oxoguanine) [119-120]. 8-0xoguanine is a common
mutagenic DNA lesion which is formed abundantly by intracellular
oxidation and exogenous carcinogens like cigarette smoke [86, 121]. It
has also been shown that cigarette smoke induces other forms of DNA
damage, including single-strand breaks (SSBs) [59, 62] and possibly
double-strand breaks (DSBs) [122-123]. In general, strand breaks result
from the attack of a variety of endogenous and exogenous factors to the
sugar residues of DNA [124]. SSBs represent the initial DNA damage and
are often used as a biomarker of exposure [125-127]. DSBs are
considered to be more biologically relevant since they can lead to
chromosome translocation and cancer if repaired improperly in addition to
genetic instability and cell death if left unrepaired [128]. Cellular DNA
repair capacity is of particular importance since it is a primary factor in
how well a cell can overcome DNA insults by a genotoxic agent. An intact
DNA repair system is crucial in order to combat the effects of various
carcinogens which can induce DNA damage.
HPV-transfected cervical cells were chosen since it has been
proposed that cigarette smoke has a late stage synergistic effect in the
cervical carcinogenesis already initiated by HPV infection [15, 129]. In
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order to study the role and possible mechanisms of cigarette smokeinduced DNA damage in the cells we employed Single Cell Gel
Electrophoresis (SCGE), also known as the comet assay. It is a sensitive
technique to detect DNA strand breaks as well as assess DNA repair
kinetics at the single cell level [125, 130]. We have employed comet assay
[131-132] to investigate (i) single- and double-strand DNA breaks following
exposure of the

HPV16-transformed human ectocervical cell

line

(ECT1/E6 E7) to cigarette smoke condensate (CSC); (ii) the ability of the
cells to repair CSC-induced DNA damage; and (iii) the possibility of
oxidative damage as the source of CSC-induced DNA strand breaks by
employing ellagic acid (EA) as a known scavenger of reactive oxygen
species [133-134].

B.

Materials and Methods

1.

Materials

Keratinocyte serum-free medium (K-SFM), bovine pituitary extract
(BPE),

epithelial

growth

factor

(EGF),

penicillin/streptomycin,

trypsin/EDTA solution and low-melting agarose were from Invitrogen
(Carlsbad, CA, USA); sodium N-Iauroyl sarcosine, DMSO, Tris and
spermine were from Sigma Aldrich (St. Louis, MO, USA); proteinase K
was from Roche (Switzerland); EDTA was from Mallinckrodt Chemicals
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(Hazelwood, MO, USA); and ellagic acid was from LKT Laboratories (St.
Paul, MN, USA).

2.

Preparation of

esc

University of Kentucky research cigarettes (2R4F) were smoked in
a Borgwardt 30-port smoking machine under standard FTC protocol [135].
The particulates were collected on Cambridge filters and were dissolved in
DMSO to obtain a 4% solution. The stock cigarette smoke condensate
solutions were stored in small aliquots at -80° C. A fresh vial was used for
each experiment.

3.

DNA damage formation

HPV-16 transformed human ectocervical cells, ECT1/E6 E7, were
a generous donation by Dr. Raina Fichorova, Brigham and Women's
Hospital, Harvard Medical School. The cells were routinely cultured as
monolayer in K-SFM supplemented with 0.3% BPE, 0.1 ng/ml EGF, 0.4
mM CaCI 2, 1% penicillin and streptomycin at 37°C and 5% CO2. Cells were
seeded at a density of approximately 6,000 cells/cm2 in 25 cm 2 cell culture
flasks. After cells reached 60 to 70% confluence, they were treated with
either 0.2% v/v DMSO or with 4, 8 and 12 Ilg/ml CSC in DMSO for up to
96 h in order to induce the maximum DNA strand breaks and then
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harvested by trypsin/EDTA solution. The cells were kept on ice at all times
to minimize the DNA repair. All cell culture studies were performed
independently three or four times.

4.

DNA repair

ECT1/E6 E7 cells were treated with 4, 8 or 12 Ilg/ml CSC for 72 h,
followed by CSC withdrawal. Residual CSC was removed by washing the
cells three times with 5 ml medium, followed by incubation of the cells with
the fresh medium for an additional 24, 48, or 72 h at 37°C to allow repair
of DNA strand breaks to occur.

5.

Ellagic acid treatment

ECT1/E6 E7 cells were pre-treated with EA (5 or 15 11M, 0.2%
DMSO) for 20 h. Following this, medium was removed and fresh media
containing CSC (4, 8 or 12 Ilg/ml, 0.2% DMSO) and EA (5 or 15 11M, 0.2%
DMSO) were added for 72 h. Vehicle (0.2% DMSO)-treated controls were
analyzed in parallel.
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6.

Comet Assay

DNA single- and double-strand breaks were detected by alkaline
and neutral comet assays, respectively, as described [130-131]. Briefly,
100,000 cells per slide were embedded in 1% low-melting agarose on
frosted microscopic glass slides. The cells were subsequently lysed (1.25
M NaCI, 0.1 % sodium N-Iauroyl sarcosine, 50 mM Na-EDTA, 100 mM
Tris-HCI, pH 10), digested with proteinase K (1.25 M NaCI, 5 mM EDTA, 5
mM Tris-HCI, 0.5 mg/ml proteinase K, pH 10) and DNA precipitated (50%
ethanol, 1 mg/ml spermine, 20 mM Tris-HCI, pH 7.4).
For single-strand breaks, the DNA was unwound by first soaking
the slides in strong alkaline buffer (10 mM Na-EDTA, 3 M NaCI, pH 13)
and then electrophoresed in the same buffer (26 V; 400 mA, at 4°C). For
double-strand breaks, the DNA was uncoiled using a neutralizing buffer
(500 mM Na-EDTA, 0.2% DMSO, 500 mM NaCI, 100 mM Tris-HCI, pH 9)
and then electrophoresed in the same buffer (26 V; 250 mA at 4°C).
After staining the cells with ethidium bromide, comets were
visualized using a light microscope attached to a digital camera with 510
excitation and 590 emission filters. The images were analyzed using the
software Comet Assay IV. (Perspective Instruments, Haverhill, UK). A total
of 50 cells per slide and 2 slides per sample were scored for "tail length"
and "tail moment". Tail length is defined as the distance between the
center of the comet head and the end of the tail. Tail moment is often
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considered a more significant indicator of DNA damage since it refers both
to the distance of DNA migration and the amount of DNA in the tail [136].
The higher the values of tail length and tail moment, as computed by the
software, the higher the level of DNA damage.

c.

Statistical analysis

The differences between comet assay mean values were analyzed
for statistical significance (p < 0.05) using Student's t-test. Statistical
analysis of dose response was calculated using one-way Analysis of
Variance (ANOVA).

D.

Results

1.

Effect of

esc on DNA strand breaks with time

Figure 2.1 depicts the typical comet-like appearance of DNA strand
breaks. ECT1 E6/E7 cells were treated with vehicle and 8 !-Ig/ml CSC for
24, 48, 72, and 96 h (Fig. 2.2). The cell viability, as measured by trypan
blue dye exclusion, following a dose of 8 !-Ig/ml CSC (up to 72 h) was

~

80% contributing to lower background damage and therefore considered
ideal to study time response (data not shown). Since the rate of induction
of single- and double-strand breaks was almost the same (as described
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below} only single-strand breaks were measured. There was a timedependent increase (Figure 2.2) in cells with single-strand breaks for both
tail length, (2.9 fold; p < 0.0001), and tail moment (14.4 fold; P = 0.0109),
at 72 h, compared to 0 h. Beyond 72 h, the tail length and tail moment
plateaued. Taking this into account, the 72 h time point was chosen to
conduct the DNA damage and repair studies, since the maximum DNA
strand breaks occurred at this treatment time.

2.

Single- and double-strand breaks induced by different doses

ofCSC

Cells treated with CSC showed a clear dose-response with respect
to the tail length and tail moment from 4-12 !-Ig/ml of CSC for both singleand double-strand breaks (p < 0.0001) (Figure 2.3). The rate of singleand double-strand break occurrences was essentially the same at all
doses tested at 72 h of CSC treatment for tail length. The tail moment for
double-strand breaks was slightly lower as compared to single-strand
breaks, although not statistically significant.
Doses of CSC higher than 12 !-Ig/ml had a lethal effect on the cells
(not shown). Treatment of the cells with 12 !-Ig/ml CSC for 72 h generated
the longest comet tail indicating the largest number of strand breaks,
which represents an increased number of DNA fragments. Panels 3c and
3d represent the number of cells with single- and double-strand breaks,
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respectively distributed at certain tail lengths following treatment with 0, 4,
8, and 12 IJg/ml concentrations of CSC; increase in concentration of CSC
indicates a greater number of strand breaks.

3.

DNA repair studies

A significant amount of both single- and double-strand breaks were
repaired in the first 24 h following treatment with 4, 8 and 12 IJg/ml CSC
for 72 h (Figure 2.4): At the highest concentration of CSC, tail length and
tail moment of single strand breaks were repaired by 27% and 32%,
respectively after 24 h; tail length and tail moment of double-strand breaks
were repaired by 21 % and 44%, respectively at the same concentration.
No further removal of either single- or double-strand breaks was observed.
DNA repair at the two lower concentrations of CSC followed essentially
the same kinetics (Figure 2.4).

4.

Ellagic acid and oxidative damage

Cells treated with 5 11M EA showed a reduction in the level of
single-strand breaks measured both as tail length (9%) and tail moment
(15%) although not statistically significant (Figure 2.5). At a higher dose
(15

11M)

of

EA,

however,

single-strand

breaks

were

diminished

significantly - 28% (p = 0.0019) reduction in tail length and 50% (p =
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0.0115) reduction in tail moment (Figure 2.5). The tail length of doublestrand breaks were also significantly reduced by nearly 8% (p
and 14% (p

= 0.0042)

= 0.0076)

with 5 and 15 11M EA treatment, respectively. The

tail moment, however, was unaltered.

E.

Discussion

It has been reported that cigarette smoke has a late stage
synergistic effect in cervical carcinogenesis initiated by HPV infection [15,
129]. Nonetheless, the mechanism of smoking on the neoplastic
progression of cervical cells remains inconclusive. The aim of this study
was to investigate CSC-induced DNA damage and subsequent repair in
HPV-immortalized cervical cells. In order to further understand the
interplay of smoking and cervical carcinogenesis, we employed the comet
assay to

measure single- and

double-strand

DNA damage

and

subsequent repair.
The principle of the comet assay is based on alterations found in
DNA such as strand breaks resulting in the extension of DNA loops from
lysed and salt-extracted nuclei, which, in turn, form a comet-like tail after
either alkaline electrophoresis, indicating SSBs, or neutral electrophoresis,
indicating DSBs [130, 137]. In previous studies in which the effects of
cigarette smoke condensate/cigarette smoke on DNA strand breaks were
investigated by the comet assay, only DNA single-strand breaks were
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detected [62, 138-139]. The interaction of

ese

on DNA strand breaks in

HPV-transformed cervical cells has not been reported previously.
In the present study, we showed that

ese in

HPV-infected cervical

cells is able to induce similar levels of DNA single- and double-strand
breaks in a dose- and time-dependent manner. Based on experimental
and epidemiological studies, cigarette smoke accounts for a significant
risk factor in developing cancer of various organs [42], including those of
the cervix [26, 43-44]. Numerous genotoxic effects of

ese,

including DNA

strand breaks, have also been demonstrated in other human culture cells
[59-62, 140]. However, this finding has not been demonstrated previously
in HPV-infected cervical cells. We speculated that DNA integrity is
compromised when cigarette smoke acts in conjunction with HPV in the
cells. Nonetheless, the effects of

ese as a heterogeneous component on

the extent of DNA damage in the cells are complex. Moreover, since

ese

consists of many tumor promoters such as catechol and hydroquinone
[141] as well as inhibitors such as unsaturated aldehydes [142], it is
difficult to pinpoint the specific carcinogens, present in

ese,

which are

responsible for DNA strand breaks. Our finding supports epidemiological
data suggesting that cigarette smoke acts in synergy with HPV in cervical
carcinogenesis.
In the current study, single- and double-strand breaks were two
types of DNA damage investigated. SSBs are considered an indicator of
early damage [125]. Also, SSBs are intermediate processing products of

37

DNA damage, which, if left unrepaired, may develop into mutagenic and
lethal double-strand breaks [143]. Conversely, DSBs are considered more
biologically relevant lesions [125]. DSBs are a more disruptive form of
strand break since they can either lead to cell death or loss of genetic
information, if left unrepaired, or they may cause neoplastic progression if
the repair process is compromised [128, 144].
Since the DNA repair capability is an important factor believed to
influence the outcome of DNA damage, we examined the repair efficiency
of HPV-transformed cervical cells in combating CSC-induced strand
breaks. From our results, it appears that cells attain DNA single- and
double-strand breaks at all concentrations of CSC tested and that
maximum repair of DNA single- and double-strand breaks occurred during
the first 24 h and plateaued afterwards. The present study also suggests
that the repair of CSC-induced DNA damage occurred only during the first
24 h and no further repair was observed. This trend was observed for both
single- and double-strand breaks. This observation is in agreement with
radiation-induced SSBs in leukocytes [145] and SSBs and DSBs in mouse
embryo fibroblasts [125]. In the latter study, in contrast to the current
findings, SSBs were completely repaired after 24 h post radiation,
whereas DSBs were not [125]. Additionally, based on our repair studies,
the ability of the cells to repair CSC-induced DNA strand breaks reached a
plateau after first 24 h regardless of CSC concentration. Therefore, it can
be concluded that the cellular repair response depends on the cell type,
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the nature of strand breaks, the type of carcinogen as well as the DNA
repair capacity of the cells. It is possible that at CSC concentrations lower
than the ones tested in this study, ECT1/E6 E7 cells endure less strand
breaks, which could be repaired efficiently. However, if DNA repair
capacity of the cells is compromised due to the HPV infection, the CSCinduced breaks may be poorly repaired which may lead to the
accumulation of mutations.
It has been reported that HPV infection compromises the DNA
repair system such as alteration in gene amplification, expression of DNA
repair enzymes [146] and microsatellite instability [147]. It is conceivable
that expression and function of genes responsible for the repair of strand
breaks might be responsible for the differences in the rate of the repair of
CSC-induced damage. The repair of HPV16-immortalized ectocervical
epithelial cells to PAHs, such as benzo(a)pyrene (BP), present in cigarette
smoke, was found to be impaired due to reduced p53 in those cells [148].
Moreover, BP has been shown to manipulate multiple HPV life cycle
functions, which, in turn, may influence cervical cancer progression [149].
Cigarette smoke may also contribute to the deficiency of DNA
repair in rejoining of the strand breaks. In this study, both single- and
double-strand DNA breaks were highly persistent. We found that CSCinduced DNA damage was much more persistent than ionizing radiationinduced damage which was completely repaired within 2 h [62]. This
finding might be due to genotoxic compounds present in CSC which have
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been shown to slow DNA repair kinetics [62]. It has been reported that
acrolein, also a constituent of cigarette smoke, was found to inhibit the
repair of DNA damage [150]. Therefore, it is reasonable to conclude that
impaired DNA repair by CSC may have a role in fixation of DNA damage
in cervical cells, leading to accumulation of mutations and cancer
development.

In theory, SSBs should be repaired by using the

undamaged strand as a template, whereas DSBs can be repaired by two
repair pathways, namely homologous recombination or non-homologous
end-joining [125, 151]. Indeed, further investigation is required to identify
the repair pathway that may have been affected in the CSC-induced
cervical cells. To the best of our knowledge, this is the first demonstration
of the kinetics of CSC-induced DNA strand breaks and of global repair of
the damage in human cervical cells.
In order to investigate if free radicals are the source of oxidative
DNA damage, we examined the effect of an antioxidant, EA, in mitigating
CSC-induced DNA damage. In our investigation, EA showed significant,
dose-dependent reduction in CSC-induced single- and double-strand
breaks. Cigarette smoke contains a broad range of carcinogens, including
redox-active catechols, which may lead to the induction of oxidative stress
and eventually contribute to increased genomic instability and cancer
development [152-153], including cervical cancer [154]. It has been
reported that the highly reactive hydroxyl radicals generated from Cigarette
smoke contribute in the formation of DNA single-strand breaks in vitro [59,
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120]. EA is a phenolic lactone that exerts its anticarcinogenic and
antimutagenic

activities

through

several

mechanisms,

including

scavenging reactive oxygen species [133, 155-156]. This observation is in
agreement with previous studies investigating the antioxidant activities of
EA on DNA strand breaks [157-158]. Our data suggest that CSC-induced
DNA strand breaks may, in part, originate from free radicals.
Interestingly, we found that EA did not significantly reduce basal
levels of both single- and double-strand breaks. Based upon our findings,
we speculate that there may be two possible explanations for the lack of
attenuation of basal levels of DNA strand breaks. First, cigarette smoke
contains more than 5,000 chemicals with diverse interactions [158], which
may influence the effectiveness of EA to act as an antioxidant. Second, in
our laboratory, it has been reported that EA was a potent inhibitor of
dibenzo[a,l]pyrene-DNA adducts in a microsome-mediated test system by
~

75% [159]. However, using a cellular system, EA inhibited the same

adducts by only 16% [160]. Thus, it seems reasonable to speculate that, in
the present study, limited EA uptake by the cells may be a possibility for
lower inhibition of CSC-induced oxidative stress in the presence of the
antioxidant. Despite the fact that EA has antioxidant activity and is a direct
radical scavenger [133], the mechanisms by which EA can further reduce
DNA strand breaks induced by CSC in the cervical cells await further
study. There are ongoing experiments in this laboratory to further
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investigate whether reactive oxygen species are a source of CSC-induced
DNA damage in the HPV- infected cervical cells.
In conclusion, our study highlights the inability of HPV-transfected
cells to completely repair CSC-induced DNA damage. Furthermore, we
demonstrated that the oxidative stress may be the source of DNA damage
caused by CSC. The significance of our study stems from the fact that
DNA lesions and/or persistent DNA strand breaks [89], caused by the
inability of the cells to remove the damage, may result in accumulation of
mutations leading to cancer. These findings support the previously found
epidemiological association between HPV infection, cigarette smoke
exposure and cervical cancer development [46, 161]. Our result suggests
that cigarette smokers infected with HPV may be at a higher risk for
cervical cancer.
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Figure 2.1: Representative comet assay images showing single-strand
breaks in DNA of ECT1/E6 E7 cells treated with vehicle, 0.2% DMSO (a),
and 4 (b), 8 (c) and 12 (d) Ilg/ml CSC for 72 h.
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CHAPTER III

CIGARETTE SMOKE CONDENSATE-INDUCED OXIDATIVE DNA
DAMAGE AND ITS REMOVAL IN HUMAN CERVICAL CANCER CELLS
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A.

Introduction
A role of cigarette smoking as a causative factor in the

development of cervical cancer was proposed by Winkelstein [41].
Considering the fact that the cause of cervical cancer is multifactorial and
HPV infection alone is not sufficient but necessary in its etiology, the
interaction of HPV and cigarette smoke has been proposed [44-46]. The
effects of cigarette smoke as a heterogeneous component on the extent of
oxidative DNA damage in cells are two-fold. First, the tar and gas-phase of
smoke are rich

sources of free radicals,

such as the quinone-

hydroquinone-semiquinone system and nitric oxide [162], which can
induce different oxidative DNA lesions, such as 8-oxo-7,8-dihydro-2'deoxyguanosine (8-oxodG) [163]. Second, the involvement of cigarette
smoke free radicals in carcinogenesis has been well documented and
reviewed elsewhere [75, 164-165]. The levels of oxidative base lesions
were reported higher in smokers as compared to non-smokers [84-86].
Insight into the mechanisms by which DNA of high-risk HPV transforms
cervical cells arose from the realization that the virus oncoproteins interact
with specific cell regulatory proteins. The E6 oncoprotein causes
degradation of the cellular protein p53 by the ubiquitin-proteasome
pathway; the E7 oncoprotein interacts with the retinoblastoma protein and
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inactivates it [32]. The tumor suppressor p53 primarily functions as a
transcription factor, but several responses can be generated by p53,
including cell cycle arrest or apoptosis [93]. The status of p53 in cervical
cancer has previously been investigated. It appears that the inactivation of
the normal function of p53 is a critical step in human cervical
carcinogenesis, which can be either caused by mutation, as in HPVnegative cells [166], or from complex formation with E6 oncoproteins in
case of HPV-positive cervical cancer cells [97].
HPV-positive cervical cancer cells have been shown to possess
residual p53 activity indicating that p53 is not completely inactivated by
binding to E6 oncoprotein [107-109]. These findings might indicate the
possibility of p53 involvement in HPV-positive cells' response in removing
the oxidative DNA damage. There is evidence that p53 has a more
positive role in facilitating the repair of oxidative lesion by its involvement
in base excision repair (BER), a DNA repair pathway [167]. However, the
existence of p53-independent repair pathway should also be considered
since cells devoid of HPV sequence did not show a p53-mediated
response to oxidative DNA damage [168].
This work was designed to investigate i) the effect of CSC on 8oxodG formation in and its removal from HPV-transfected (ECT1/E6 E7),
HPV-positive (CaSki) and HPV-negative (C33A) human cervical cancer
cells; and ii) the cell-cycle progression and apoptosis in the CSC-treated

ECT1/E6 E7 cells. The transfected cell line was chosen as a standardized
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in vitro model [169] to further understand the interplay of cigarette smoke

free radicals and cervical carcinogenesis.

B.

Materials and Methods

1.

Cell Lines and cell culture

HPV-16 transformed human ectocervical cells, ECT1/E6 E7, were a
generous donation by Dr. Raina Fichorova, Brigham and Women's
Hospital, Harvard Medical School. HPV-16 positive human cervical cells,
CaSki, and HPV-negative human cervical cells, C33A, were purchased
from ATCC (Manassas, VA). ECT1/E6 E7 cells were cultured as
monolayer in K-SFM supplemented with 0.3% BPE, 0.1 ng/ml EGF, 0.4
mM CaCI 2 , 1% penicillin and streptomycin at 37°C and 5% CO 2 . CaSki and
C33A cells were routinely cultured in RPMI-1640 media supplemented
with 5% fetal bovine serum (FBS) in a humidified atmosphere of 5% CO 2
in air at 37°C. All the cell lines were seeded at a density of approximately
6,000 cells/cm 2 in 25 cm 2 cell culture flasks. All the cell lines were
authenticated by DNA (STR) profiling at the Core Fragment Analysis
Facility at Johns Hopkins University on March, 15, 2010.
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2.

Preparation of

esc

University of Kentucky research cigarettes (2R4F) were smoked in
a Borgwardt 30-port smoking machine under standard FTC protocol [135].
The particulates were collected on Cambridge filters and were dissolved in
DMSO to obtain a 4% solution. The stock CSC solutions were stored in
small aliquots at -80°C. A fresh vial was used for each experiment.

3.

8-oxodG formation

CSC treatment of the cells was carried out as described
elsewhere [170]. Briefly, after cells reached 60 to 70% confluence, they
were treated with either 0.2% v/v DMSO or with 4, 8 and 12 Ilg/ml CSC in
DMSO for up to 72 h in order to induce the maximum oxidative DNA
damage and then harvested by trypsin/EDTA solution. The cells were kept
on ice at all times to minimize the DNA repair. 8-oxodG formation was
measured by flow cytometry.

4.

DNA repair

The cells were treated with 4, 8 or 12 Ilg/ml CSC for 72 h. Residual
CSC was removed by washing the cells three times with 5 ml medium,
followed by incubation of the cells with the fresh medium for an additional
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24, 48, or 72 h at 37°C to allow repair of oxidative DNA damage to occur.
Subsequently, 8-oxodG levels were measured by flow cytometry.

5.

Flow cytometry and ImageStream analysis of 8-oxodG and p53

expressions

Primary polyclonal goat anti-8-0HdG antibody was purchased from
Chemicon International; and primary polyclonal goat anti-p53 antibody
was purchased from Santa Cruz biotechnology. Briefly, all cell lines were
harvested and fixed in 70% ethanol and stored at -20°C for later
processing. Upon thawing, cells were washed one time in phosphate
buffered saline (PBS) followed by another wash with FACS buffer (1 %
BSA in PBS). Next, cells were permeabilized with 0.1 % Triton-X-100 for
20 minutes on ice at room temperature (RT), followed by washing with
PBS. For 8-oxodG staining, primary antibody (1-3 mg/ml) was incubated
with Zenon Fab-Alexa Fluor 488 goat IgG labeling reagent (5 Ill)
(Invitrogen, Carlsbad, CA), and cells were stained for 30 min at room
temperature in dark. Alternatively, to stain for p53, fixed, washed and
permeabilized cells were stained with 1 Ilg p53 primary antibody labeled
with 5 III of the Zenon Fab-Alexa Fluor 488 goat IgG labeling reagent for
30 min at room temperature in dark. Cells were washed with FACS buffer.
For nuclear staining, 106 cells were incubated with 0.25 Ilg of 7-AminoActinomycin D (7 AAD; BD-PharMingen) resuspended in FACS buffer and
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analyzed within 30 min. Around 5 x 104 cells were analyzed by flow
cytometry using a FacsCalibur flow cytometry and CeliQuest™ software
(Becton-Dickenson, USA) to assess cell cycle, apoptosis and p53
expression. Expression of p53 was defined in terms of total fluorescent
intensity, which was calculated by multiplying number of cell events by
mean intensity. Correspondingly, 104 stained cells were analyzed using an
ImageStream System and IDEAS 3.0 software (Amnis) to assess 8-oxodG
expression. 8-oxodG total fluorescent intensity was calculated by
multiplying the cell events by mean fluorescent intensity.

6.

Cell cycle analysis

Cell cycle phase distribution of ECT1/E6 E7 cells was analyzed by
flow cytometry (BD Biosciences, San Jose, CA). CSC-treated cells and
appropriate controls (2 x 105 ) were collected after 24 h, washed twice with
PBS and fixed with ice-cold 70% ethanol at 4°C for 30 min to 1 h. The
cells were then treated with 10 Ilg/ml propidium iodide (PI, Sigma- Aldrich,
St. Louis, MO), 2.5 Ilg/ml RNase A (Sigma- Aldrich, St. Louis, MO) and
0.1% Triton X-100 in dark at 37°C for 30 min. Data were collected, stored
and analyzed using FlowJo software (Becton Dickinson).
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7.

Apoptosis detection

Apoptosis in ECT1/E6 E7cells was detected using an Alexa Fluor®
488 annexin V/propidium iodide kit (Invitrogen Co., Carlsbad, CA),
according to the manufacturer's instructions. Briefly, 1 x 106 cells were
treated with vehicle or 4, 8, 12 Ilg/ml CSC for 24 h. After harvesting, cells
were washed with cold PBS, and then stained with 5 III annexin V-FITC
and 0.1 Ilg/ml propodium iodide (PI) for each 100 III of cell suspension
and incubated at room temperature for 15 min. The apoptotic cells were
determined using FACScalibur flow cytometry (Becton Dickinson, San
Jose, CA). Data analysis was performed using FlowJo software (Becton
Dickinson). It is important to note that a quadrant quantification method
could not be used in apoptotic cell determination, since CSC treatment
affected the cells' distribution using that method. Therefore, both early
apoptotic (Annexin V-positive and PI-negative) and late apoptotic (Annexin
V-positive and PI-positive) cells were determined in the cell death
determination.

c.

Statistics

The total fluorescent intensity levels are expressed as the mean ±
SD (standard deviation) and analyzed for statistical significance (p < 0.05)
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using Student's t-test. Statistical analysis of dose response was calculated
using One-way Analysis of Variance (ANOVA).

D.

Results

1.

8-0xodG formation in HPV-transfected cervical cells

A significant increase (3-fold; p

= 0.004)

in 8-oxodG level was

detected following treatment of cells with 12 Ilgfml CSC for 24 h compared
with vehicle treatment (Fig. 3.1 a,b); the 8-oxodG levels were further
increased (3-fold; p

= 0.01) after 72 h (Fig.

lesion was both dose- (p

= 0.01)

3.1 c,d). Formation of 8-oxodG

and time- (p

= 0.002)

dependent (Fig.

3.1 e,f).

2.

8-0xodG removal in cervical cells

To examine the ability of cervical cells to remove CSC-induced
oxidative DNA damage, we investigated the residual 8-oxodG total
fluorescent intensity for different periods of recovery time. The highest
level of oxidative DNA damage measured as total fluorescent intensity x
105 was found to be in ECT1 fE6 E7 cells (104 ± 19), followed by CaSki
(2.7 ± 0.71) and C33A (0.66 ± 0.083) cells.
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ECT1/E6 E7 and C33A cells showed a 3- (p

= 0.007) and 2-fold (p

= 0.02) increase in 8-oxodG level in the first 24 h, respectively (Fig.

3.2a,

c, iv). In contrast, a 3-fold (p = 0.07) decrease in oxidative damage was
observed in CaSki cells in the first 24 h (Fig. 3.2b, iv). However, 8-oxodG
lesion was essentially removed from all the cell lines by 72 h (Fig. 3.2a, b,
c: i, ii, iii, iv).

3.

p53 assessment in cervical cells

The different cervical cells treated with vehicle or CSC during the
repair phase of 8-oxodG were also analyzed for p53 levels in order to
elucidate its involvement in cell cycle phase distribution, apoptosis
induction, and removal of oxidative DNA lesion. As quantified by flow
cytometry. p53 total fluorescent intensity was increased by 2 and 5 fold in
ECT1/E6 E7 (Fig. 3.3a) and CaSki cells (Fig. 3.3b), respectively, but it
was diminished by 1.7 fold in C33A cells (Fig. 3.3c).

4.

Cell cycle phase distribution in HPV-transfected cervical cells

p53 is non-functional in cervical cells harboring HPV infections due
to the co-expression of the E6 oncoprotein. Therefore, a CSC-induced cell
cycle arrest is not expected in these cells. To test this, we investigated the
cell cycle changes in immortalized cervical cells after CSC exposure for 24
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h. Nearly one half (46.6%) of vehicle-treated cells were at G1 phase,
24.9% in S phase and and 28.3% in G2 phase. After treatment with CSC

(12 Ilg/ml), the G1 phase cells increased to 60.3% while the proportion of S
phase decreased to 17.4%. However, there was no significant change in
percentage of cells in G2 phase post-CSC exposure (Fig. 3.4). These data
suggest that CSC treatment resulted in GoIG 1 phase arrest.

5.

Apoptosis induction in HPV-transfected cervical cells

We examined the percentage of cells going through apoptosis as a
possible mechanism by which CSC affects cells. CSC treatment induced
apoptosis, as evidenced by a dose-dependent increase in the percentage
of apoptotic cells at 24 h treatment in ECT1/E6 E7 cells: 9.7% of vehicletreated cells were apoptotic which increased to 11.5%, 16.6%, and 26.6%
after treatment with 4, 8, 12 Ilg/ml CSC treatment, respectively. Fig. 3.5
depicts the effect at the highest concentration tested.

E.

Discussion

We previously showed that CSC can induce both dose- and timedependent single- and double-strand breaks in cervical cells [170]. In the
present study, we show that CSC induces 8-oxodG lesion in a dose- and
time-dependent fashion in the HPV-transfected cervical cell line, ECT1/E6
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E7. It is well documented that cigarette smoke or its components induce
oxidative DNA damage [58], which is believed to be highly mutagenic and
carcinogenic [171]. In the present study, the highest levels of oxidative
DNA damage was observed by treatment of cervical cells with 12 Ilg/ml
CSC for 72 h. This highlights the inherent vulnerability of cervical cancer
cells to CSC-induced oxidative stress; a dose- and time-related increase
in 8-oxodG lesion in cervical cells emphasizes the important role of the
CSC-induced oxidative DNA damage in cervical carcinogenesis. Our
finding supports epidemiological and experimental data suggesting that
cigarette smoke induces oxidative stress.
Furthermore, our data showed that there is a difference in the
extent of DNA damage between HPV-transfected and -positive cell lines.
We observed that ECT1/E6 E7 cells showed a much higher level of CSCinduced oxidative damage compared to CaSki cells. One possible
explanation is that the immortalized cells may be more prone to oxidative
injury. This is in agreement with the study of Wilmer and coworkers who
showed that cystinotic cell lines immortalized with HPV E6/E7 appear to
show increased oxidative stress and altered redox status compared to
control cells [172]. C33A cells showed the lowest level of 8-oxodG in
response to CSC compared with ECT1/E6 E7 and CaSki cells. This
observation might be due to the lack of synergistic impact of HPV on CSCinduced oxidative DNA damage in C33A cells, which are devoid of HPV
sequences. This contrasts with the studies of Wei et al. that showed the
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DNA damage and mutation were decreased in cells harboring high risk
HPV infection in response to nitric oxide, a source of oxidative damage
resulting from cigarette smoking [173]. Nonetheless, we speculate that
carcinogenic HPV induces a higher burden of oxidative DNA damage in
cervical cells, which may directly point to the critical role of HPV in CSCinduced oxidative injury.
Oxidative DNA damage has been shown to trigger activation of
several cellular processes, such as apoptosis and cell cycle checkpoint, in
order to

maintain

cellular homeostasis

[174].

The

current study

demonstrates that in addition to increasing 8-oxodG lesion levels in
cervical cells, CSC can induce a dose-dependent increase in apoptosis in
ECT1/E6 E7 cells with an arrest at GoIG 1 phase of cell cycle. However,
CSC-induced apoptosis occurred in small percentages of cells. The
remaining surviving cells may undergo proliferation, which, in turn,
compromises the genomic integrity of the cells by increasing the
possibilities of accumulation of DNA mutations. Similar observation was
reported by Liu et al. on the effect of cigarette smoke extract on human
bronchial epithelial cells [175]. The fact that almost 50% of cells resist the
cell cycle arrest as shown in this study may also playa role in genomic
instability; these cells have altered function, which may eventually
contribute to cervical pathogenesis. These results also suggest that DNA
repair processes can be initiated in response to DNA damage by cigarette
smoke since many cells undergo oxidative DNA damage, apoptotic
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activation pathway and cell cycle checkpoint but survive; these cells may
harbor genomic instability.
Intriguingly, 8-oxodG removal was most efficient (93%) in HPVpositive CaSki cells

compared to HPV-negative C33A, which did not

reveal any significant removal of the oxidative DNA damage up to 48 h.
Different scenarios could be considered to explain the differences in the
responses of HPV-positive and -negative cell lines to CSC-induced
oxidative DNA damage in the present study. One possibility may be due to
the residual activity of p53 that has been reported in cervical cancer cells
[108-109]; CaSki cells have the highest basal p53 activity [107]. Our data
support these findings that basal p53 activity exists in CaSki cells, and to
some extent in ECT1/E6 E7 cells, despite the co-expression of the viral E6
oncogene. However, C33A, containing mutant p53 genes lacked the p53mediated response to DNA damage [108]. In concordance with the notion
that the p53 protein is functional in HPV-infected cells, we observed that
oxidative DNA damage was removed most efficiently in the following
order: CaSki > ECT1/E6 E7 > C33A. These findings suggest that the
presence of residual p53 activity in HPV-infected cells may have a role in
removal of oxidative DNA damage.
Our data clearly showed that expression of p53 differed between
HPV-positive and -negative cervical cells in response to CSC-induced
DNA damage. The data revealed that p53 expression was not altered in
C33A. In contrast, in HPV-positive cells, p53 expression was higher during
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the removal phase of the oxidative DNA damage. These findings are
congruent with the results of several studies indicating the existence of
residual wild-type p53 activity in cervical carcinoma cells [108-109]. The
authors showed HPV-positive cancer cells contained enough p53 to
elucidate the activity of a downstream p53 upon exposure to genotoxic
stress. On the other hand, Kessis et al [176] showed that DNA damage
could not stimulate p53-dependant activities in HPV 16 E6-expressing
cells. This finding was due primarily to an augmented E6 response
generated by constitutive promoters. The observation that the HPVnegative cells could achieve the same level of DNA repair after 72 h postexposure along with their unaltered p53 expression may thus provide
possible evidence for the existence of the p53-independent repair pathway
[168]. This is due to the inactivation of p53 by the mutation of the gene in
these cells [99, 177]. The precise mechanistic pathway responsible for the
delayed repair in C33A and HPV-transfected cells as compared to HPVpositive cells requires further investigation.
The notion that p53 plays a role in BER is supported by the
observation that the cell extracts expressing wild-type p53 exhibit an
enhanced BER response, which was later abolished upon p53 depletion
[167]. Further, a study by Zhou et al. has suggested that p53 is directly
involved in BER, which might be due to its dual functions: as a responder
of DNA damage and also as an active participant in repairing the induced
damage [178]. These studies directly support our findings that p53 may
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have played an integral role in removal of the CSC-induced oxidative
damage in the cells expressing wild-type p53 despite the co-expression of
the E6 oncogene.
It is of interest to note that oxidative DNA damage was sharply
increased in the first 24 h after withdrawal of CSC in HPV-transfected and
-negative cells. A similar observation of a transient increase of oxidative
DNA damage following cessation of smoke exposure in the lung of A/J
mice has been made [83]. This finding could be explained by the
heterogeneous nature of CSC, including carcinogens, promoters, tumor
inhibitors, and DNA repair inhibitors [62, 179]. Thus, the transient increase
in oxidative DNA damage detected in our studies could possibly be due to
the effect of DNA repair inhibitors in conjunction with free radicalproducing quinones/semiquiniones in CSC.
To conclude, we have demonstrated that CSC-induced oxidative
DNA damage is more pronounced in HPV infected cells. We also have
shown that 8-oxodG was removed almost completely 72 h post-exposure
in all the cervical cell lines tested, regardless of HPV status. The similarity.
of responses to CSC-induced oxidative DNA damage between cell lines
expressing mutant p53 or the E6 oncoprotein suggests that interaction of
E6 and p53 may be functionally comparable to p53 mutations. These
observations lead us to presume the possibility of both p53-dependent
and -independent DNA repair pathways in our experimental setting.
Though CSC-induced oxidative DNA damage was eventually removed in
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all the cells, the possibility of error-prone DNA repair, however, cannot be
ruled out. Chakravarti et al. have shown that

DB[a,~P-induced

DNA

depurinating lesions are subject to error-prone excision repair in pre-Sphase cells, which generates heteroduplex mutations in the H-ras gene
[180]. The error-prone DNA repair may render cells susceptible to the
accumulation of genetic mutations associated with carcinogenesis and
tumor progression.
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Figure 3.1: Cigarette smoke condensate (CSC)-induced 8-oxodG lesion
in ECT1/E6 E7. Cells treated with vehicle for 24 h (a) and 72 h (c) and
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represent dose- and time-response to CSC-induced oxidative DNA
damage as measured by 8-oxodG total fluorescent intensity. Data
represent mean ± SD of three independent experiments (*p < 0.01 ; **p <
0.004) .
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Figure 3.2: Removal of cigarette smoke condensate (CSC)-induced
oxidative DNA damage in ECT1/E6 E7 (a), CaSki (b), and C33A (c) cells:
Cells treated with vehicle (i) and CSC (12 Ilg/ml) (ii) for 72 h, and 72 h
post

csc

exposure (iii) were stained with Alexa Flour 488-Conjugated

anti-8-0HdG, and the images were acquired by multispectral imaging flow
cytometry. (iv) denotes kinetics of removal of CSC-induced oxidative DNA
damage: rhombus (0) , square (4), triangle (8), and circle (12) Ilg/ml CSC.
Data represent mean ± SD of three independent experiments.
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Figure 3.3: Assessment of p53 expression in different human cervical

cells. ECT1/E6 E7 (a), CaSki (b), and C33A (c) cells were treated with
cigarette smoke condensate (CSC) (12 Ilg/ml) for 72 h to induce the 8oxodG lesion. Then, cells were freed of the residual CSC and further
incubated for 72 h for repair of oxidative DNA damage to occur, stained
with Alexa Flour 488-conjugated anti-p53 antibody and quantified by flow
cytometry. Data represent mean ± SO of three independent experiments
(p < 0.04).
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Figure 3.5: Cigarette smoke condensate (CSC)-induced apoptosis in
HPV-transfected cells. Apoptosis was induced with 0 (a) and 12 Ilg/ml
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represent the apoptotic and live cell populations, respectively.
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CHAPTER IV

THE INTERPLAY OF CIGARETTE SMOKING AND HPV INFECTION IN
HUMAN VAGINAL CELLS: AN EX VIVO STUDY
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A.

Introduction

Vaginal tumors account for an incidence of approximately 1-2% of
lower genital tract malignancies [3, 71] The etiology of vaginal cancer
mainly remains equivocal. Nevertheless, there are a few population-based
case-control studies for the etiology of this rare abnormality [66-68, 72].
These studies reveal that the majority of vaginal cancers have common
risk factors with cervical cancers; the most reported shared risk factor
among women with cervical and vaginal tumors is infection with cancerassociated human papillomavirus (HPV) types. High-risk HPV prevalence
is comparable in cervical and vaginal samples [14], which, in turn, signifies
that both tissues can retain cancer-associated HPV infection. However,
cervical abnormalities are far more common compared with vaginal
tumors [181]. The possible justification for the infrequent occurrence of
vaginal cancer, despite infection with cancer-associated HPV, may be due
to the different transformation potential of the virus in cervical and vaginal
tissues [182].
Other epidemiological and etiological variables associated with
cervical cancer have also been reported to be pertinent to the etiology of
vaginal tumors, such as cigarette smoking [66]. Although conflicting data
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exist on the role of smoking in the development and progression of HPV
lesions in vaginal cells [66, 183-184], the exact mechanism by which
cigarette smoking exerts its cytotoxic effects is not fully understood.
Cigarette smoke is a heterogeneous mixture of approximately
5,000 chemical compounds, of which several dozen are carcinogens, cocarcinogens, mutagens and tumor promoters [116], including polycyclic
aromatic hydrocarbons (PAHs), N-nitrosamines, inorganic and organic
compounds [118, 185]. It has been reported that cigarette smoke-induced
genotoxicity results in induction of DNA damage, such as double-strand
breaks (DSBs) [58]. Single-strand breaks are considered an indicator of
early damage [125] and they are intermediate processing products of DNA
damage, which, if left unrepaired, may develop into mutagenic and lethal
double-strand breaks [143]. DSBs are a more disruptive form of strand
break since they can either lead to cell death or genetic instability, if left
unrepaired, or they may cause neoplastic progression if the repair process
is compromised [128,144].
Previous studies with human HPV-transfected Ect1/E6 E7 cervical
cells suggested that cigarette smoke-mediated DNA DSBs are highly
persistent, which may lead to increased mutation and ultimately higher
cancer risk [170]. Hence, the effect of cigarette smoking on human vaginal
cells warrants an investigation. The aim of this study was to investigate
whether cigarette smoking, given the infection with high risk HPV types,
leads to detectable DNA damage in vaginal cells. In order to examine this,
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we employed single cell gel electrophoresis (SCGE), also known as the
comet assay. That is a sensitive technique to detect DNA strand breaks at
the single cell level [131, 186].

B.

Materials and Methods

1.

Study population

Eligible patients (n = 100) who visited the Gynecologic Oncology
Clinic at James Graham Brown Cancer Center and University of Louisville
Ob/Gyn Colposcopy Clinic during 2007 through 2009 participated in the
study (Table 4.1). Each patient was informed about the study protocol at
the time of her visit and given a written informed consent prior to the
study. Patients answered an NIH-approved questionnaire about their
medical history and smoking habits. The patients' high-risk HPV status
was obtained from hospital records and/or a detailed questionnaire. The
protocol, consent form and questionnaire for this study were approved by
the Institutional Review Board at the University of Louisville. Women who
were pregnant and/or receiving radiation/chemotherapy in the last year
prior to the time of their visit were excluded from the study. Thus, 76
subjects who satisfied the exclusion criteria were included. The study was
conducted in a blinded fashion.
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2.

Materials

Keratinocyte serum-free medium (K-SFM), bovine pituitary extract
(BPE),

epithelial

growth

factor

(EGF),

penicillin/streptomycin,

trypsin/EDTA solution and low-melting agarose were from Invitrogen
(Carlsbad, CA, USA); sodium N-Iauroyl sarcosine, DMSO, Tris and
spermine were from Sigma Aldrich (St. Louis, MO, USA); proteinase K
was from Roche (Switzerland); EDTA was from Mallinckrodt Chemicals
(Hazelwood, MO, USA).

3.

Collection of human specimens

A Dacron™ cervical swab was used to obtain vaginal material from
the lateral vaginal wall. Swabs were immediately placed in a 5-ml solution
consisting of K-SFM pre supplemented with 0.3% BPE, 0.1 ng/ml EGF,
0.4 mM CaC1 2 ,1 % penicillin and streptomycin at 4°C for up to 2h.

4.

HPV status

The assessment was made based on either the HPV testing or the
Pap results done at the time of the visit. In case HPV testing was not
done, the Pap results of low- grade squamous intraepithelial lesion
(LGSIL) or high squamous intraepithelial lesion (HGSIL) were classified as
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HPV positive. The final decision on the HPV status of each participant was
confirmed by the Gynecologic Oncologist, Dr. Lynn Parker.

5.

Smoking status

Information on the smoking history of the patients was obtained
from the questionnaires. Patients were characterized to two broad
categories: those who currently or formerly smoked (ever smoker) and
those who did not smoke (never smoker). Thus, there were 49 ever
smokers (28 current and 21 ex-smokers) and 27 never smokers.

6.

Comet assay

DNA DSBs were detected by neutral comet assay, as described
previously [131, 170, 186]. Briefly, vaginal samples were centrifuged,
washed with PBS and processed immediately. 100,000 cells per slide
were embedded in 1% low-melting agarose on frosted microscopic glass
slides. The cells were subsequently lysed (1.25 M NaCI, 0.1 % sodium Nlauroyl sarcosine, 50 mM Na-EDTA, 100 mM Tris-HCI, pH 10), digested
with proteinase K (1.25 M NaCI, 5 mM EDTA, 5 mM Tris-HCI, 0.5 mg/ml
proteinase K, pH 10) and the DNA was precipitated (50% ethanol, 1 mg/ml
spermine, 20 mM Tris-HCI, pH 7.4). DNA was unwound using a
neutralizing buffer (500 mM Na-EDTA, 0.2% DMSO, 500 mM NaCI, 100
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mM Tris-HCI, pH 9.0) and then electrophoresed in the same buffer (26 V;
250 mA at 4°C). After staining the cells with ethidium bromide, comets
were visualized using a light microscope attached to a digital camera with
510 excitation and 590 emission filters. The images were analyzed using
the software Comet Assay IV (Perspective Instruments, Haverhill, UK). A
total of 50 cells per slide and 2 slides per sample were scored for tail
length (TL) and tail moment (TM) as described before [170]. Tail length is
defined as the distance between the center of the comet head and the end
of the tail. Tail moment is often considered a more significant indicator of
DNA damage since they refer both to the distance of DNA migration and
the amount of DNA in the tail [136]. The higher the values of tail length
and tail moment, as computed by the software, the higher the level of DNA
damage.

c.

Statistical analysis

The analysis was conducted to examine the influence of age, HPV
infection, smoking and disease status as individual variables and multivariables on the extent of DNA double-strand breaks using the
generalized linear regression model [187]. The mean, standard deviation
(SO), median, minimum and maximum along with 95% confidence
intervals for TL and TM were computed within each level of the categorical
variables. The p-values were computed using the Wilcoxon rank-sum test
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between HPV positive and negative subjects, ever and never smokers,
and between old (>36 years) and young (:536 years) patients for TL and
TM. We further performed the subset analyses on smokers and nonsmokers based on their HPV status. Age was grouped using a median
cut-off and non-parametric test was used. Furthermore, we performed the
multi-variable analysis to estimate the simultaneous effects of the HPV
and smoking covariates on TL and TM. We have observed very strong
association between HPV status and disease status (p <0.001). Therefore,
age, HPV infection and smoking status were analyzed using PROC GLM
[187] in SAS system (v9), where age was considered as both a categorical
and continuous variable.

D.

Results

1.

The influence of HPV infection on induction of DNA double-

strand breaks

We investigated the potential role of cancer-associated HPV types
in inducing DNA DSBs. The percentage of women enrolled in this study
with high-risk HPV DNA was higher (n

= 46;

60.5%) compared with

women who were reported to be negative for the virus (n = 30; 39.5%).
Two most common types of DNA strand break measurements were
recorded: tail length and tail moment. The mean tail length for those who
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were infected with HPV was significantly (p < 0.001) lower (31.2 +/- 18.7
11m) compared with women who were HPV negative (61.7 +/- 22.6 11m)
(Figure 4.1, Table 4.2). These data indicate that those with HPV infection
showed a lower degree of DNA damage compared to those who did not
have HPV DNA. Similar results were found for tail moment (HPV positive,
2.4 +/- 2.8 AU; HPV negative, 8.7 +/- 4.9 AU) demonstrating the significant
(p < 0.001) inverse association between HPV infection and extent of

double-strand DNA breaks in the studied population.

2.

DNA double-strand breaks induced by cigarette smoking

We examined whether DNA strand breaks correlated with the
smoking status of the study population. The study group was (n = 76)
comprised of the population who never smoked (n = 27; 35.5%) and ever
smokers (either currently or formerly) (n = 49; 64.5%). The clinical and
general characteristics of the study population are presented in Table 4.1.
The mean tail length for never smokers was 57.7 +/- 24.5 11m. The ever
smokers group had a mean tail length of 35.3 11m +/- 21.9. We found a
significant inverse association between smoking status and tail length (p <
0.001) indicating that those who never smoked have, on average, a higher
degree of DNA DSBs compared with individuals who had reported as
smokers (Figure 4.1; 4.2, Table 4.2). Similarly, mean tail moment was 7.5
+/- 5.5 AU among never smokers compared with 3.4 +/- 3.7 AU for those
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who smoked. This finding signifies that those who never smoked showed
a higher extent of DNA strand breaks (p < 0.001).

3.

The effect of age on DNA double-strand breaks

In order to understand the effect of age on DNA damage, analysis
was carried out taking into account the age as both a continuous and
categorical variable (Table 4.2). Forty patients (52.6%) were less than or
equal to the median age of 36 and 36 patients (47.4%) were above the
median age. There were significantly higher DNA DSBs in older women
compared with younger women: mean TL of 61.2 +/- 22.5 versus 27.1 +/13.9 11m (p < 0.001) and mean TM of 8.3 +/- 5.0 AU versus 1.8 +/- 1.6 AU
(p < 0.001).

4.

The interaction between HPV infection and smoking status

Subjects with HPV-positive and -negative status were further
categorized based on their smoking status as summarized in Table 4.3.
Ever-smoker and HPV-positive women (n = 32) had significantly lower
mean TL compared to never-smoker and HPV-positive individuals (n = 14)
(23.9 ± 11.3 11m versus 48.0 ± 21.8 11m; p < 0.001). This inverse
association was also observed in mean TM (Ever smoker and HPV
positive, 1.4 ± 1.0 AU versus never smoker and HPV positive, 4.7 ± 4.1
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AU) (Figure 4.3). A non-significant association with TL (p = 0.258) and TM
(p = 0.079) was observed among smokers who were negative for HPV

infection.

5.

The interaction among HPV infection, cigarette smoking and

age

We examined the influence of HPV infection, smoking status and
age on induction of DNA DSBs in the study population (Table 4.4). Age as
either a categorical (:::;36 and >36) or continuous variable showed a strong
association when using the multivariable generalized linear regression
model. Significant association was observed between TL and HPV for age
as categorical (p = 0.019) and as continuous (p = 0.034) variable. This
finding indicates that women with HPV infection had a lower mean TL
(31.2 ± 18.7 11m) compared to HPV negative individuals (61.7 ± 22.6 11m)
regardless of their age. Similarly, TM and HPV status conferred a
significant association (p = 0.002) for age as both categorical and
continuous variable, indicating a lower TM (2.4 ± 2.8 AU) in women with
HPV infection compared with those who were HPV negative (8.7 ± 4.9
AU). The smoking status was significantly correlated with TL (57.7 ± 24.5
11m vs. 35.3 ± 21.9 11m) and TM (7.5 ± 5.5 AU vs. 3.4 ± 3.7 AU) for age as
categorical (p < 0.001) and continuous variable (p = 0.003). These
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findings suggest the negative correlation between smoking status and
DNA DSBs regardless of age.

E.

Discussion

We examined the interplay of cigarette smoking and high-risk HPV
infection on the DNA integrity of vaginal cells. Based on our experimental
findings, we confirmed that the levels of DNA double-strand breaks are
inversely correlated with both smoking and HPV status. This observation
suggests that the vaginal epithelium may have a different transformational
ability by HPV infection.
About 17 to 20% of the individuals who were approached to take
part in the study were not considered based on the defined exclusion
criteria: i) radiation/chemotherapy in a year prior to the time of visit, and ii)
current pregnancy. The rationale for excluding individuals undergoing
radiation/chemotherapy treatment was based on an earlier study reporting
that radiation treatment resulted in 5- to 6-fold increase in DNA adduct
levels, detected by 32P-postlabeling, compared with the initial level [188].
Pregnant women were excluded from the study due to an observed higher
incidence of HPV infections [189] and a more rapid progression of cervical
dysplastic lesions to carcinoma compared to non-pregnant women [190].
Moreover, progesterone induces the expression of several anogenital
HPV genes, including HPV 16, through hormone response elements
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within regulatory regions of the viral genome [191-192]. The choice of
location for collecting the vaginal specimens is one of the strengths of our
study. We collected the vaginal specimens from the lateral vaginal wall to
minimize the possible contamination by cervical and metaplastic epithelial
cells. This site-specific specimen collection was further validated by
microscopic evaluation of the mature squamous cells encompassing the
vaginal epithelium. However, we cannot rule out the possibility of sloughed
cervical cells in those vaginal samples. Nonetheless, the great majority of
the cells were mature squamous types and the homogeneous nature of
the collected samples was cytologically confirmed.
One of the intriguing findings that emerged from our study was that
HPV infection showed an inverse relation with the extent of DNA strand
breaks in the studied population. Considering that a link between high-risk
HPV and Vaginal Intraepithelial Neoplasia has been reported [193], the
induction of DNA damage by the virus is a logical hypothesis. Moreover,
even though the natural histories of cervical and vaginal lesions appear
similar [194], neoplastic and invasive vaginal abnormalities are far less
common than both cervical intraepithelial neoplasia and invasive cervical
carcinoma [181]. This obvious discrepancy may be explained by
considering two facts. One is that the vagina lacks a squamo-columnar
junction, known as transformation zone [13]. The importance of the
transformation zone is evident by the fact that most of the dysplasia
caused by persistent HPV infection frequently arises, for unknown
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reasons, in areas where two different types of epithelium merge such as
that occurring in the cervix, anus and oro-pharynx [195]. It has also been
reported that the transformation zone is more sensitive to HPV infection
[14] since the squamous metaplastic cells - constituents of the
transformation zone - are needed to support the carcinogenic alteration by
high-risk HPV [14]. Secondly, the discrepancy may also be explained by
the variable manifestations of HPV infection in the vagina compared to
that in the cervix, even though the virus infects vagina and cervix with the
same frequency [196]. HPV replication in lytic infection is more efficient
and results in producing progeny virions, which eventually destroy the
infected vaginal cells. In contrast, HPV replicates less efficiently in the
cervix and tends to remain within the cells as latent infection, a
phenomenon involved in persistence of the infection [182].
Even though persistent high-risk HPV infections account for a great
majority of cervical cancers [26, 197], cell-mediated immunity plays a
significant role in clearance of the infection within 1-2 years of exposure
[198]. There are, however, no data reported on role of HPV persistence on
DNA damage particularly in vaginal walls. Based on our experimental data
indicating decreased level of DSBs in HPV-positive individuals, we deduce
that vaginal cells may be more resistant to the DNA damaging effect of
HPV infection. This speculation was partly derived from the fact that HPV
has the ability to hinder host defenses by several means, such as the lack
of viral-induced cell death in keratinocytes and downregulation of the
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expression of interferon [198]. As part of the HPV infectious cycle, which
depends on the differentiation status of the target cell, the virus infects
primitive keratinocytes; the expression of viral proteins and viral assembly
occur at much higher level in the superficial squamous cells that are
terminally differentiated [199]. These differentiated keratinocytes that
mainly cover the vaginal wall are intended for death and desquamation.
Therefore, HPV replication, assembly and particle release do not trigger
any cytolysis, and therefore a immune response due to lack of
inflammatory reaction [198]. A limitation of the study is that the HPV status
was based on the detection of the collective presence of carcinogenic
HPV types instead of the individual HPV genotypes. Stratification of the
patients based on specific HPV genotypes may provide further insights
into the complex interrelation of smoking and progression of HPV infection
in vaginal carcinogenesis. The HPV testing used for this study, however,
employed a combination of DNA probes to test for high-risk viral types,
including HPV 16, which is the most prevalent high-risk HPV strongly
associated with vaginal carcinogenicity [67, 200-201].
Based on significant increase in DNA DSBs in HPV-negative
individuals, we infer that, in our study population, the extent of DNA
damage is independent of HPV infection. However, DNA strand breaks
were the only measured endpoint used in this study. Investigation of other
forms of HPV-associated damage, including chromosomal instabilities
[202] is warranted. Other pre-disposing factors, such as history of cervical
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and/or vaginal abnormalities, chronic irritation [3] and cigarette smoking
[68] may have an impact on DNA integrity of vaginal cells.
We have clearly shown that the extent of DNA DSBs increases as a
function of age. Our finding is congruent with the studies of Singh et al.
and Morris et al. who demonstrated an increase in DNA strand breaks with
age in human sperm [132, 203]. Additionally, age-related differences have
been reported among individuals diagnosed with cervical cancers
compared to those with vaginal cancers [71]. Carcinoma of vagina mainly
occurs in elderly women

(~

60 years) [71, 204-206]. This finding signifies

the age-associated alterations in DNA structure, such as double-strand
breaks [132] that may, in turn, attribute to genetic instability and ultimately
vaginal carcinogenesis.

The extent of double-strand DNA breaks

increases with age of the population examined, which implies that older
women are at higher risk for accumUlation of mutation and genetic
instability. Thus, the relevance of our findings to public health in identifying
high-risk population is significant.
Our analysis demonstrated a significant inverse correlation
between DNA strand breaks and smoking habit. Data on smoking was
obtained by self-reporting smoking history. However, the smoking history
was obtained prior to medical examination, which minimizes the chance of
reporting inaccurate smoking habit (underestimation or denial) among the
participated

women

in

the

study.

Furthermore,

measurement

of

biochemical parameters such as cotinine, thiocyanate and carbon
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monoxide are not considered to be impeccable due to several factors,
such as short half-life of smoking by-products in the body [207]. Selfreporting smoking history, when compared with biochemical validation,
has been reported to have sensitivity and specificity of above 85% [207].
Few studies, however, have reported a positive association
between cigarette smoking and vaginal abnormalities [67-70]. These
studies were based on an epidemiological association that appears to link
cigarette smoking with vaginal cancer. In contrast, in the current study,
DNA strand breaks, as a biological endpoint, was measured to provide
insights into the mechanistic effect of the cigarette smoking on the etiology
of vaginal cancer. We found no positive correlation between smoking and
vaginal abnormalities. In contrast, two other studies found a nonsignificant epidemiological association with smoking in vaginal carcinoma
[71-72]. Furthermore, oxidative DNA damage caused by treatment with
cigarette smoke condensate were repaired in HPV-transfected, HPVpositive and HPV-negative human cervical cancer cells with equal
efficiency, which may be attributed to p53-dependent and -independent
DNA repair pathways (Chapter III). We infer from this and other studies,
that cigarette smoke exposure can alter the mechanisms of gene
expression or their functions, which may, in turn, have a variable effect on
DNA integrity. Equally important, we cannot overlook the confounding
cumulative

effects

of

polymorph isms

in

DNA

repair genes,

the

heterogeneous nature of cigarette smoke constituents, and exposure to
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other environmental factors in evaluating the influence of smoking on
HPV-mediated vaginal tumorigenesis.
The role that cigarette smoking plays in the development and/or
progression of HPV infection is convoluted and not yet entirely
understood. Our data derived from the ex-vivo study clearly showed an
inverse relationship between the interaction of cigarette smoking and HPV
infection in the induction of DNA strand breaks regardless of age. These
findings are not in aggreement with the results of Sellors et al., who
reported that smoking was not a risk factor for HPV infection or
persistence [184]. On the contrary, in several studies elevated levels of
tobacco related carcinogens such as benzo[a]pyrene and nitrosamine 4(methylnitrosamino )-1-(3-pyridyl)-1-butanone (N NK) were identified in
cervical mucosa of cigarette smokers compared to non-smokers [53, 55,
57]. It is worth noting that the systemic effect of tobacco smoke on vaginal
epithelium may not manifest itself by DNA DSBs, the only endpoint
investigated in this study. Importantly, the scarcity of literature on the
biological effects of cigarette smoke on vaginal epithelium provide us with
a challenging and unique prospect to caution ourselves in making a
generalized statement from a public health perspective.
In conclusion, we found that HPV infection, cigarette smoking and
the interaction between the two have a significant inverse relation with
DNA DSBs detected in vaginal epithelium of the population studied. To the
best of our knowledge, there are no other studies that assessed any DNA
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damage endpoint in vaginal cells in relation to smoking and HPV infection
status. Lack of DNA damage in HPV-positive patients may partially explain
the relatively lower incidence of vaginal cancers compared to cervical
cancers subsequent to HPV infection. Even though the overall conclusion
is restricted by the small sample size, the highly differentiated nature of
vaginal squamous cells and lack of persistence of HPV infection may
partly explain

the

negative

association

between the

investigated

parameters. Previous findings are supportive of this notion where a
reduction in DNA strand breaks of human cervical cancer cells was
observed by ellagic acid [170], a polyphenol present in significant amounts
in berries. Therefore, the higher degree of DNA damage in older women
may signify the benefits of consumption of foods rich in antioxidants. From
an etiological point of view, further studies with broader scope and larger
sample size are required to elucidate the impact of cigarette smoking as a
cofactor in vaginal carcinogenesis.
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Figure. 4.1: Representative comet assay images. Panel (A) depicts

intact nuclei in a HPV positive individual. Panel (8) shows DNA doublestrand breaks in a HPV negative participant. Panels (C) and (D)
represent double-strand breaks in DNA of never and ever smokers,
respectively.
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Figure. 4.2: Scattered plot presentation of the OSBs in the studied

population. Panels represent the distribution of (A) tail length and (B)
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Figure 4.3: Correlation between HPV infections and smoking status
presented by scattered plot in the studied population. Panel (A) represents
the distribution of tail length (A 1) and tail moment (A2) in HPV positive
women. Panel (8) depicts the distribution of tail length (81) and tail
moment (82) in HPV negative individuals with respect to smoking status
(p < 0.001) . Lines signify the mean.
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Table 4.1. Clinical and General Characteristics of the
Studied Population
Characteristics
Numbers (0/0)
76 (100)

Total
Age
Mean ±SD
Median (Min-Max)

40.6± 17.1
36.0 (18.0-80.0)

White
African American
Unknown

50

Race
15
11

H PV Infection
Positive
Negative

46 (61)
30 (39)

Never
Ever

27 (36)
49 (64)

Normal
LGSIL
HGSIL

30 (39)
16 (21 )
30 (39)

Smoking Status

Pap/Pathology Status
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Table 4.2. Comet Assay Measured in the Vaginal Cells of the Subjects

\0
UJ

Numbers{%l

Mean TL:l:SO

95% CI

PValues

HPV Infectio n
Positive
Negative

46 (61 )
30 (39)

31 .2:1:18.7
61 .7:1: 22 .6

25.2 - 37.2
54.3 - 69 .1

<0.001

Smoking Status
Never
Ever

27 (36)
49(64)

57.7:1: 24.5
35 .3:1: 21 .9

48.9 - 66.5
28.8 - 41.8

40 (52.6)
36 (47.4)

27.1:1:13.9
61.2:1: 22.5

22.8 - 31.4
53.9:1: 68.6

MeanTM

so

95% CI

PValues

2.4:1: 2.8
8.7:1: 4.9

1.3-3.5
7.3 -10 .0

<0.001

<0.001

7.5:1:5.5
3.4 ± 3.7

5.8 - 9.3
2.1 - 4.7

0.001

<0.001

1.8:1: 1.6
8.3 :1:5.0

1.3-2 .3
6.6 - 9.9

<0.001

:I:

Age
S36(% )

>36(%)

Age
Continuous
Est. ± SE

<0.001
1.07:1: 0.12

<0.001
0.20:1: 0.02

Table 4.3. Comet Assay Measured in the Vaginal Cells of the Subjects Stratified for HPV
and Smoking Status
Numbers{%}

MeanTL:t SO

PValue

MeanTM :t SO

PValue

Never
Ever

14 (18)
32 (42)

36.9± 21.9
23.9 ± 11.3

<0.001

4.7±4.1
1.4 ± 1.0

<0.001

Never
Ever

13 (17)
17 (22)

68 .1 ± 23.6
56.8±21.1

0.258

10.7 ± 5.4
7.2 ± 4.0

0 .079

HPV Positive
\0
~

HPV Negative

Table 4.4. Generalized Linear Regression Model on Age, Smoking and HPV Status
Dependent

\0
VI

Intercept
Est.
PValue

HPV Positive
Est.
PValue

Ever SmokinQ
Est.
PValue

TL

59 .56

<0.001

-13.015

0.019

-15 .318

<0 .001

TM

7.2

<0.001

-3.419

0.002

-2 .852

<0.001

TL

16.93

0.0155

-11 .312

0 .034

-12.582

0 .003

TM

0.61

0 .644

-3.298

0.002

-2.468

0.003

Age as Categorical

Age as Continuous

CHAPTER V

SUMMARY AND GENERAL DISCUSSION
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A.

Major Findings
The experiments performed in Chapter II of this dissertation were

designed to test the hypothesis that cigarette smoke is a major cofactor in
cervical carcinogenesis. We examined the role of CSC in inducing DNA
damage in a HPV-transfected human cervical cell line (ECT1/E6 E7).
Additionally, the effect of ellagic acid, a potent antioxidant protective
against the

CSC-induced

oxidative

DNA damage was examined.

Experiments described in Chapter III were built on results of Chapter II,
and examine the role of CSC in induction and removal of oxidative DNA
damage. The selection of a human cervical cancer cell line was expanded
to include both HPV-positive (CaSki) and -negative cervical cancer cells
(C33A) in addition to HPV-transfected cells in order to further investigate
the effect of CSC on the induction of oxidative DNA damage in association
with HPV. Chapter IV is an ex vivo study, which focuses on examining the
role of cigarette smoking and high risk HPV infection in human vaginal
cells. Specific findings of these chapters are described below.
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1.

Cigarette smoke condensate can induce DNA strand breaks

As noted in Chapter II, cigarette smoking is one of the major risk
factors in HPV-mediated cervical cancer, since it has been consistently
linked with the progression of cervical neoplasia [15]. In fact, female
smokers are at two times higher risk of developing cervical cancer than
non-smokers [208]. The mechanism of smoking in mediating neoplastic
transformation of cervical cells, however, remains inconclusive and was
the main question of this chapter. Experiments were designed to
investigate CSC-induced DNA damage and subsequent repair in HPVimmortalized cervical cells.
First, a time- and dose-response of CSC on human ECT1/E6 E7
was determined. Next, we employed single-cell gel electrophoresis, also
known as the comet assay, to further examine the role of CSC in the
induction of DNA single- (SSBs) and double-strand breaks (DSBs). To
investigate the ability of the cells to repair CSC-induced DNA strand
breaks, the residual DNA damage subsequent to removal of CSC was
further determined by the comet assay. In order to investigate if free
radical-producing constituents of CSC are the source of DNA damage, we
examined the effect of an antioxidant, ellagic acid, in mitigating CSCinduced DNA damage.
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The major findings of this chapter are that CSC can induce DNA
strand breaks in human HPV-transfected cells in a time- and dosedependent fashion. Equally important is the fact that our study reveals the
inability of HPV-transfected cells to entirely repair CSC-induced DNA
damage. Additionally, we have also demonstrated that oxidative stress
may be the source of DNA damage caused by CSC. The data presented
in this chapter suggest that persistent DNA strand breaks caused by the
inability of the cells to remove the damage may result in accumulation of
mutations leading to cancer [89]. These findings provide experimental
evidences that support the previously reported epidemiological association
between

HPV

Infection,

cigarette

smoking

and

cervical

cancer

development [46, 161].

2.

Cigarette smoke condensate can

induce oxidative

DNA

damage

One of the findings of this dissertation is that CSC can be a source
of oxidative stress (Chapter II), which serves as a building block to further
investigate the effect of CSC in association with HPV infection in human
cervical cancer cells (Chapter III). The rationale for the experiments
designed in this chapter was based on the epidemiological and
experimental findings that cigarette smoke or its components induce
oxidative

DNA

damage

[58],
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such

as

8-oxo-7 ,8-dihydro-2'-

-----------------------------

deoxyguanosine (8-oxodG), which is highly mutagenic and carcinogenic
[171]. In fact, the levels of oxidative base lesions were reported higher in
smokers as compared to non-smokers [84-86]. Therefore, the goal of this
chapter was to determine the effect of CSC on oxidative DNA damage
formation and its removal from HPV-transfected (ECT1/E6 E7), HPVpositive (CaSki) and HPV-negative (C33A) human ceNical cancer cells.
We further investigated the cell cycle progression and apoptosis in the
CSC-treated ECT1/E6 E7 cells as a standardized in vitro model [169] to
further understand the effect of cigarette smoke-free radicals and ceNical
carcinogenesis.
In this chapter, the role of tumor suppressor p53 as a transcription
factor and regulator of cell cycle arrest or apoptosis [93] was also
examined. It appears that the inactivation of the normal function of p53 is
a critical step in human ceNical carcinogenesis, which can be either
caused by mutation, as in HPV-negative cell [166] or from complex
formation with E6 oncoproteins in the case of HPV-positive ceNical cancer
cells [97].
The major finding of this chapter is the first demonstration of
oxidative DNA damage induced by cigarette smoke constituents and its
repair in human ceNical cancer cells using multispectral imaging flow
cytometry techniques.
These data suggest that CSC-induced oxidative DNA damage is
more pronounced in HPV-infected cells. Furthermore, we showed that 8-
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oxodG was removed almost completely 72 hours post-exposure in all
cervical cell lines tested, regardless of HPV status. The similarity of
responses to CSC-induced oxidative DNA damage between cell lines
expressing mutant p53 or the E6 oncoprotein suggests that interaction of
E6 and p53 may be functionally comparable to p53 mutations. These
observations lead us to infer the possibility of both p53-dependent and independent DNA repair pathways in our experimental setting. Although
CSC-induced oxidative DNA damage was eventually removed in all cells,
the possibility of error-prone DNA repair, however, cannot be ruled out,
which may lead to the accumulation of genetic mutations associated with
carcinogenesis and tumor progression.

3.

Cigarette smoking and HPV infection act independently in

vaginal cells

Our in vitro findings (Chapters II and III) showed that CSC can
induce DNA strand breaks as well as oxidative DNA damage. Moreover,
our previous studies with human HPV-transfected ECT1/E6 E7 cervical
cells suggested that cigarette smoke-mediated DNA DSBs are highly
persistent, which may lead to increased mutation and ultimately higher
cancer risk [170]. These findings led us to design an ex vivo study to
further examine the role of cigarette smoking in human vaginal cells. The
rationale behind the selection of vaginal cells, which are mature squamous
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types, is to obtain a homogenous sample. The main objective of Chapter
IV was to investigate whether cigarette smoking, given the infection with
high-risk HPV types, would produce DNA damage in vaginal cells.
Conflicting data exists on the role of smoking in the development
and progression of HPV lesions in vaginal cells [66, 183-184]; the exact
mechanism by which cigarette smoking exerts its cytotoxic effects is not
fully understood. Results from Chapter IV of this dissertation directly
support a negative association of smoking with vaginal abnormalities,
which is in agreement with the two other studies, where a non-significant
epidemiological relationship was found [71-72].
Age-related differences have been reported among individuals
diagnosed with cervical cancer compared with those women with vaginal
cancer [71]. Carcinoma of vagina mainly occurs in individuals older than
60 years old [71, 204-206]. Our study showed a clear positive correlation
between age and DSBs detected in vaginal cells of the studied population.
This finding signifies the age-associated alterations in DNA structure, such
as double-strand breaks [132] that may, in turn, attribute to genetic
instability and ultimately vaginal carcinogenesis.
The endpoint measured in this chapter was DNA DSBs, which can
lead to chromosome translocation and cancer if improperly repaired, in
addition to genetic instability and cell death if left unrepaired [128].
Considering that a link between high-risk HPV and Vaginal
Intraepithelial Neoplasia has been reported [193], the induction of DNA
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damage by the virus is a logical hypothesis. However, this hypothesis has
not been directly tested, nor do our results support this theory. This may
be due to the variable manifestations of HPV infection in the vagina
compared to those in the cervix, even though the virus infects the vagina
and cervix with the same frequency [196].
The most intriguing findings of this chapter is that the HPV infection
and cigarette smoking have a significant inverse relation with DNA doublestrand breaks detected in vaginal epithelium of the population studied.
Also, non-smokers with HPV infection tend to have more DNA DSBs
compared to smokers, while there was no difference between smokers
and non-smokers who had no HPV infection. There are no data reported
as to DNA lesions in vaginal cells in relation to smoking and HPV infection
status. This investigation suggests that vaginal cells differ in response to
carcinogenic HPV infection and cigarette smoking, due to variety of
factors, such as lytic versus latent HPV infection in vaginal and cervical
cells, respectively, and resistance of highly differentiated vaginal epithelial
cells to HPV.

4.

DNA Strand Breaks Detection

The rational for detecting DNA double-strand breaks in vaginal cells
was based on the finding that single-strand breaks were not detectable in
64% of the vaginal samples, whereas only in 25% of the samples DNA
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double-strand breaks were undetectable. There is no report in the
literature indicating such observations. The samples with undetectable
single- and/or double-strand breaks were categorized as "undefined".
Table 5.1 depicts the summary of comet assay data for all 101 samples
along with their representative images.

B.

Strengths and Weaknesses of this Dissertation

1.

Strengths

This dissertation has many points of strength. First, it solidifies the
role of cigarette smoke on the induction of DNA strand breaks and
oxidative damage in human cervical cancer cells. Although there have
been epidemiological and experimental findings on the causal role of
cigarette smoke on DNA integrity of various organs, a biological endpoint
demonstrating cytotoxic effects of cigarette smoke in human cervical
cancer cells was provided by this work. Second, there has been
speculation about the association of cigarette smoking, as an important
cofactor, with high-risk HPV infection in cervical carcinogenesis. This
study further supports the persistence of cigarette smoke-associated DNA
damage in the presence of HPV infection, which may lead to accumulation
of mutations in cervical cells and ultimately higher cancer risk. Third,
literature on the biological effects of cigarette smoke on vaginal epithelium
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is scarce. This work further contributed to the limited body of knowledge in
understanding the interplay of cigarette smoking and HPV infection in an
unprecedented ex vivo study. This work also suggests that cigarette
smoking and HPV infection have a significant inverse relation with DNA
double-strand breaks detected in vaginal epithelium of the studied
population.
Furthermore, the extent of double-strand DNA breaks increases
with age of the population examined, which is suggestive that older
women might be at higher risk for accumulation of mutation and genetic
instability. Therefore, the relevance of our findings to public health in
identifying high-risk population is significant.
From a technical standpoint, the strength of this work was using a
cell-based analysis known as the comet assay. It is a sensitive technique
used to detect DNA strand breaks as well as assess DNA repair kinetics
at the single-cell level [125, 130]. The advantages of the comet assay
compared with other genotoxicity assays include i) sensitivity to detect low
levels of DNA damage [209]; 2) use of small number of cells per sample
[210]; 3) automated analysis [211]; 4) completion of an experiment in
relatively short time [212]; 5) relatively low cost [213]; and 6) application to
all nucleated eukaryotic cells [214]. Due to the various advantages of
comet assay, it has been applied in diverse studies [214] including in vivo
genotoxicity testing [215]. In previous studies in which the effects of
cigarette smoke condensate/cigarette smoke on DNA strand breaks were
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investigated by the comet assay, the focus was only on SSBs [62, 138139]. DSBs are a more disruptive form of strand break compared with
SSBs, since they can either lead to cell death or loss of genetic
information if left unrepaired, or they may cause neoplastic progression if
the repair process is compromised [128, 144]. Therefore, both single- and
double-strand breaks were detected in this work (Chapters II).
Furthermore, we employed state-of-the-art multispectral imaging
flow cytometry to detect and visualize oxidative DNA damage in human
cervical

cancer cells

(Chapter III).

This

work

benefited from

a

sophisticated and yet undisputable visualizing approach to identify
cigarette smoke-induced oxidative DNA damage. The oxidative DNA
damage can be indirectly visualized with a microscope by immunostaining with anti-8-0HdG antibody. The ImageStream automatically and
objectively acquires thousands of images to quantify a specific lesion in
single population of cells more efficiently than regular flow cytometer,
since the obtained information on the cells can be further expanded to
measure various parameters ..
Another strength of this work is the use of cell culture experiments
(Chapters II and III). This experimental setting is suitable to understand
the

mechanistic

effect

of

cigarette

smoking

under

a

controlled

environment, allowing the results of these studies to be translated to in
vivo models. This work also employed an ex vivo study (Chapter IV),
which allows the results of such studies to be better translated to the
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human disease. Such studies provide data as proof-of principle, which
may serve as a building block toward developing early biomarkers in
identifying high-risk population.

2.

VVeaknesses

The main focus of this dissertation was to investigate the effect of
cigarette smoke on DNA damage and repair in human cervical and vaginal
cells mainly due to its role as a significant cofactor in association with
high-risk HPV infection in cervical/vaginal carcinogenesis. However, there
are many other forms of damage (i.e. DNA base bulky adducts, DNA
cross links, etc.) that can potentially attribute to mutagenicity of those
diseases.
Chapter II and III investigate the role of cigarette smoke in HPVtransfected cells using a standardized in vitro model [169] in cervical
carcinogenesis. However, it could be beneficial to study HPV-negative
normal cervical cells to address the role of HPV infection as either
dependent or independent factor as well as to further investigate the
possible effect of cigarette smoking (additive or synergistic) in association
with HPV infection. It is noteworthy that several unsuccessful attempts
were made to culture HPV-negative normal cervical cells.
One of the limitations of Chapter III was the inability to investigate
the role of p53 in DNA repair pathways. Our data demonstrated that the
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level of oxidative stress induced by cigarette smoke condensate is higher
in HPV-positive compared with HPV-negative cervical cancer cells, and
that the removal of the damage takes place by p53-dependent and independent DNA repair pathways. It may be useful to confirm the results
of activation, or lack thereof, of p53 protein expression in human cervical
cancer cells by performing western blotting.
Chapter IV investigated whether cigarette smoking, given the
infection with high-risk HPV types, leads to detectable DNA damage in
vaginal cells by employing the comet assay. One of the advantages of this
study was to examine DNA integrity at a single-cell level. However,
double-strand break detection might not be the only cigarette smoking
induced damage in these cells. The study may very well benefit from
detection of other biological endpoints, such as single-strand breaks,
oxidative DNA damage, bulky DNA adducts, etc. It is worth noting that
remaining vaginal samples were preserved in formalin for future studies.
One of the limitations in researching the association of smoking with HPV
infection (Chapter IV) is a lack of information on the duration and intensity
of smoking for the study population. The smoking information used in this
study was based on self reporting. The association between self reporting
and biochemical validation is approximately 85% [207] and could
potentially influence the data interpretation. These data could contribute to
further establish a correlation of the factors investigated. Another limitation
is that the presented HPV data was based on the detection of the
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collective presence of carcinogenic HPV types instead of providing
information on the individual HPV genotypes. Therefore, it may be useful
to determine specific HPV genotypes in order to provide further insights
into the complex interrelation of smoking and HPV infection in vaginal
carcinogenesis.

c.

Future Directions

Future directions described herein are intended to address issues
stated in Weaknesses (Chapter V). The rationale behind these proposed
experiments is to strengthen the findings of this dissertation, although
these future projects are independent of the completion of this
dissertation.

1.

Does cigarette smoke induce other forms of damage in human

cervical cancer cells?

Cigarette smoke-induced genotoxicity results in induction of
micronuclei,

sister chromatid

exchange,

chromosomal

aberrations,

microsatellite instability, DNA strand breaks [58] and oxidative DNA
damage [75, 165]. It has been well established that cigarette smoke
accounts for a significant risk factor in developing cancer of various
organs [42], including those of the cervix [43-44]. However, a mechanistic
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approach to investigate other forms of damage caused by cigarette smoke
in cervical cells has not been pursued. Therefore, a future study could
investigate the effect of cigarette smoke in those cells and establish a
correlation with HPV infection to broaden the knowledge in cervical
carcinogenesis.

2.

Does cigarette smoking and/or HPV infection induce oxidative

damage in vaginal cells?

Cigarette smoke has been shown to cause a variety of oxidative
DNA damage, including the formation of 8-oxodG [119-120]. 8-oxodG is a
common

mutagenic

DNA

lesion

which

is formed

abundantly by

intracellular oxidation and exogenous carcinogens like cigarette smoke
[86, 121]. Mentioned previously, cell blocks of the collected human vaginal
samples were also prepared at the time of sample processing. These
samples

can

be

used

to

investigate

8-oxodG

expression

by

immunohistochemistry method. This information further adds to the scarce
body of knowledge on the effect of cigarette smoking in vaginal cells.

D.

Significance of this Study

As mentioned throughout this dissertation, cigarette smoking
accounts as a significant cofactor in cervical/vaginal carcinogenesis. The
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significance of the study in Chapter II stems from the fact that DNA lesions
and/or persistent DNA strand breaks caused by the inability of the cells to
remove the damage, may result in accumulation of mutations leading to
cancer [89].
In Chapter 1111 of this dissertation, the detection of oxidative DNA
damage and its repair in human cervical cancer cells by multispectral
imaging flow cytometry analysis was reported. The detection and
visualization of oxidative DNA damage in human cervical cancer cells are
novel findings of this study, which may serve as early biomarkers of
cancer. This is the first demonstration indicating higher degree of 8-oxodG
by cigarette smoke constituents in HPV-positive compared to -negative
human cervical cells.
To date, there are no other studies that assess a biological
endpoint such as DNA strand breaks in vaginal cells in relation to smoking
and HPV infection status (Chapter IV). This finding builds on the limited
knowledge on the effect of cigarette smoking as a cofactor in vaginal
carcinogenesis.

1.11

----------------

E.

Final notes

There are number of factors associated with carcinogenic HPV
infection of the cervix and vagina that have been implicated in
development and progression of cervical/vaginal cancers. Cigarette
smoking represents the strongest cofactor [66]. However, in depth
experimental investigation is needed to link the numerous epidemiological
findings as well as to understand the molecular mechanisms of high-risk
HPV-associated vaginal cancer. Indeed, it is not yet clear if all vaginal
cancers can be attributed to cofactors such as cigarette smoking in
association with oncogenic HPV infection. Finally, the exact mechanism
by which cigarette smoke mediates carcinogenesis could provide
prophylactic and therapeutic applications that could

ultimately be

beneficial to women at high risk of or diagnosed with HPV-induced
cervical/vaginal abnormalities.
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Table 5.1
Com rehensive Comet Data
10#

SM
Status

HPV
Status

Mean
TL

Mean

TM

(AU)
(!.1m)
_ _ _ _L -_ _ _ _

~

Alkaline

Mean
TL

Mean

TM

(AU)
(!.1m)
_ _ _ _L -_ _

~

~

Neutral

VG -60

Never

Pas

Undef.

Undef.

38.01

3.79

VG -61

Ever

Neg

51 .29

9.07

71.88

10.63

VG-62

Never

Neg

49.44

6.49

87.43

13.69

VG-63

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-64

Ever

Neg

56.33

9.03

63.82

8.13

VG -65

Never

Neg

Undef.

Undef.

42.89

4.82

VG-67

Ever

Neg

Undef.

Undef.

39.59

3.55

VG-68

Ever

Neg

Undef.

Undef.

49.82

3.24
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Rep. Comet
Image
Alkaline

Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL

(I.lm)

Mean
TM
(AU)

Alkaline

Mean
TL

(I.lm)

Mean
TM
(AU)

Neutral

VG-70

Ever

Neg

Undef.

Undef.

65.31

8.68

VG-71

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-72

Ever

Pas

NA

NA

53.85

4.25

VG-73

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-74

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-75

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-76

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-77

Ever

Neg

Undef.

Undef.

21.43

1.15

VG-78

Never

Neg

102.9
7

28.38

113.76

20.5

VG-79

Never

Pas

18.28

96.08

10.32

VG-80

Never

Pas

Undef.

60.10

5.14

100.3

3

Undef.
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Rep. Comet
Image
Alkaline

Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL
(~m)

Mean
TM
(AU)

Alkaline

Mean
TL
(~m)

Mean
TM
(AU)

Neutral

VG-81

Never

Pas

55.11

9.91

73.53

12.91

VG-82

Never

Pas

62.12

11 .17

72.13

12.01

VG-83

Ever

Neg

43.00

7.25

76.05

14.34

VG-84

Never

Neg

77.62

17.77

86.74

15.01

VG-85

Never

Neg

53.86

8.70

60.49

9.92

VG-86

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-87

Never

Neg

55.38

10.02

67.21

7.43

VG-88

Ever

Neg

Undef.

Undef.

59.56

6.64

VG-89

Ever

Neg

47.25

8.29

64.80

8.28

VG-90

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-91

NA

NA

Undef.

Undef.

Undef.

Undef.
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Rep. Comet
Image
Alkaline

Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL
(~m)

Mean
TM
(AU)

Alkaline

Mean
TL
(~m)

Mean
TM
(AU)

Neutral

VG-92

Ever

Neg

67.73

16.98

76.35

10.94

VG-93

Never

Neg

Undef.

Undef.

16.64

0.19

VG-94

Never

Neg

66.94

15.59

74.94

12.98

VG-95

Never

Neg

55.45

10.66

72.81

13.81

VG-96

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-97

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-98

Never

Neg

62.98

10.63

83.49

15.44

VG-99

Ever

Neg

Undef.

Undef.

77.26

8.21

VG-100

Never

Neg

11.60

56.71

5.62

VG-101

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-102

Never

Neg

49.67

10.83

65.33

10.05

VG-103

Ever

Neg

48.65

11.51

61 .86

9.10

VG-104

Ever

Neg

Undef.

Undef.

14.18

0.23

50.08
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Rep. Comet
Image
Alkaline

Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL
(~m)

Mean
TM
(AU)

Alkaline

Mean
TL
(~m)

Mean
TM
(AU)

Neutral

VG-105

Ever

Neg

63.00

11.39

70.34

9.87

VG-106

Never

Neg

60.34

12.41

57.27

8.41

VG-107

Ever

Neg

Undef.

Undef.

17.45

0.85

VG-108

Ever

Neg

61 .11

13.73

60.68

8.29

VG-109

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-110

Ever

Neg

65.93

13.86

74.91

9.67

VG-111

Never

Pas

Undef.

Undef.

22.47

0.92

VG-112

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-113

Ever

Pas

Undef.

Undef.

13.03

0.45

VG-114

Ever

Pas

Undef.

Undef.

15.57

0.41

VG-115

NA

NA

Undef.

Undef.

Undef.

Undef.

VG-116

Ever

Pas

Undef.

Undef.

46.19

1.99
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Rep. Comet
Image
Alkaline

Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL

(J.lm)

Mean
TM
(AU)

Alkaline

Mean
TL

(J.lm)

Mean
TM
(AU)

Neutral

VG-117

Ever

Pes

Undef.

Undef.

16.44

1.03

VG -118

Never

Pes

Undef.

Undef.

34.74

4.00

VG -119

Ever

Pes

Undef.

Undef.

29.91

1.70

VG-120

Ever

Pes

Undef.

Undef.

17.98

1.47

VG -121

NA

NA

Undef.

Undef.

Undef.

Undef.

VG -122

Ever

Pes

Undef.

Undef.

25.91

2.04

VG -123

Ever

Pes

Undef.

Undef.

35.73

1.24

VG-124

Never

Pes

Undef.

Undef.

40.28

2.56

VG-125

Ever

Pes

43.19

8.30

35.08

1.76

VG -126

Ever

Pes

Undef.

Undef.

25.79

1.84

VG -127

NA

NA

Undef.

Undef.

Undef.

Undef.
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Rep. Comet
Image
Alkaline

Rep. Comet
Image
Neutral

10#

SM
Status

HPV

Status

Mean
TL
(IJm)

Mean
TM
(AU)

Alkaline

Mean
TL
(IJm)

Mean
TM
(AU)

Rep. Comet
Image
Alkaline

Neutral

VG -128

Ever

Pas

Undef.

Undef.

16.55

1.03

VG -129

Ever

Pas

Undef.

Undef.

45.83

2.45

VG -130

Never

Pas

Undef.

Undef.

42.92

2.41

VG -131

Never

Pas

Undef.

Undef.

29.49

1.65

VG-132

Ever

Pas

Undef.

Undef.

20.29

1.08

VG-133

Never

Pas

Undef.

Undef.

51.52

4.96

NA

VG -134

Ever

Pas

Undef.

Undef.

15.50

0.77

NA

Ever

Pas

Undef.

Undef.

12.87

0.23

NA

Ever

Pas

Undef.

Undef.

28.18

3.97

NA

Pas

Undef.

Undef.

54.71

2.71

NA

Pas

Undef.

Undef.

46.46

3.01

NA

Ever
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Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL

(!.1m)

Mean
TM
(AU)

Alkaline

Mean
TL

(!.1m)

Mean
TM
(AU)

Rep. Comet
Image
Alkaline

Neutral

VG -141

Ever

Pas

Undef.

Undef.

13.09

0.31

NA

VG-1

Ever

Pas

Undef.

Undef.

16.15

0.66

NA

VG -1

Never

Pas

Undef.

Undef.

15.83

0.71

NA

VG -1

Ever

Pas

Undef.

Undef.

17.69

0.64

NA

VG -1

Ever

Pas

Undef.

Undef.

19.82

1.58

NA

VG -1

NA

NA

Undef.

Undef.

Undef.

Undef.

NA

VG -147

Never

Pas

Undef.

Undef.

39.95

1.77

NA

VG -148

Ever

Pas

Undef.

Undef.

18.54

0.49

NA

VG -149

Ever

Pas

Undef.

Undef.

20.11

1.27

NA

VG -150

Ever

Pas

Undef.

Undef.

15.64

0.40

NA

VG-151

Ever

Pas

Undef.

Undef.

17.85

0.95

NA

VG-152

Ever

Pas

Undef.

Undef.

15.44

0.89

NA
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Rep. Comet
Image
Neutral

10#

SM
Status

HPV
Status

Mean
TL
(IJm)

Mean
TM
(AU)

Alkaline

Mean
TL
(IJm)

Mean
TM
(AU)

Rep. Comet
Image
Alkaline

Neutral

0.84

NA

22.57

0.84

NA

Undef.

14.91

0.34

NA

Undef.

Undef.

Undef.

Undef.

NA

Pes

Undef.

Undef.

32.15

2.44

NA

NA

NA

Undef.

Undef.

Undef.

Undef.

NA

VG -158

Ever

Pes

Undef.

Undef.

14.75

0.55

NA

VG -159

Ever

Pes

Undef.

Undef.

24.31

1.75

NA

VG -160

NA

NA

Undef.

Undef.

Undef.

Undef.

NA

VG -153

Ever

Pes

Undef.

Undef.

VG-153

Ever

Pes

Undef.

Undef.

VG -154

Ever

Pes

Undef.

VG-155

NA

NA

VG -156

Ever

VG -157

TL: tail length
TM: tail moment
AU: arbitrary unit
NA: not available
SM: smoking
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22.57

Rep. Comet
Image
Neutral
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ABBREVIATIONS

HPV: Human Papillomavirus
SSBa: Single-Strand Breaks
DSBa: Double-Strand Breaks
CSC: Cigarette Smoke Condensate
LSIL: Low-grade Squamous Intraepithelial Lesion
HSIL: High-grade Squamous Intraepithelial Lesion
T -ZONE: Transformation Zone
pRb: Retinoblastoma protein
PAHa: Polycyclic Aromatic Hydrocarbons
NNK: nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
BP: benzo[a]pyrene
ROS: Reactive Oxygen Species
8-oxodG: 8-oxo-7 ,8-dihydro-2'-deoxyguanosine
BER: Base Excision Repair
SCGE: Single Cell Gel Electrophoresis
TL: Tail Length
TM: Tail Moment
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